







A Thesis Submitted for the Degree of PhD at the University of Warwick 
 







Copyright and reuse:                     
This thesis is made available online and is protected by original copyright.  
Please scroll down to view the document itself.  
Please refer to the repository record for this item for information to help you to cite it. 
Our policy information is available from the repository home page.  
 


































This thesis is submitted in partial fulfilment of the requirements for the 





Coventry University, Faculty of Health and Life Sciences 




     ii 
 
Table of Contents 
List of Tables and Figures ................................................................................................ v 
List of Abbreviations ........................................................................................................ vi 
Acknowledgements ......................................................................................................... viii 
Declaration ........................................................................................................................ ix 
Summary ............................................................................................................................ x 
Chapter One ............................................................................................................... 1 
Predictors of anxiety in autism spectrum disorder: a systematic review ............. 1 
Abstract ....................................................................................................................... 2 
1.1 Introduction .......................................................................................................... 3 
1.1.1 Anxiety in autism ................................................................................................... 3 
1.1.2 Impact of anxiety .................................................................................................... 4 
1.1.3 Factors associated with anxiety .............................................................................. 5 
1.1.4 Rationale ................................................................................................................ 5 
1.1.5 Aims ....................................................................................................................... 6 
1.2 Method ................................................................................................................... 6 
1.2.1 Literature Search .................................................................................................... 6 
1.2.2 Inclusion and Exclusion Criteria ............................................................................ 7 
1.2.3 Classification of Studies ......................................................................................... 9 
1.2.4 Quality Assessment .............................................................................................. 11 
1.2.5 Characteristics of Studies ..................................................................................... 13 
1.3 Results ......................................................................................................................... 31 
1.3.1 Social skills and behaviour ................................................................................... 31 
1.3.2 Sensory sensitivities ............................................................................................. 32 
1.3.3 Cognitive and executive related skills .................................................................. 33 
1.3.4 Emotional regulation and awareness .................................................................... 34 
1.3.5 Physiological arousal ........................................................................................... 34 
1.3.6 Language ability ................................................................................................... 35 
1.3.7 Demographic variables ......................................................................................... 35 
1.3.8 Face processing .................................................................................................... 36 
1.3.9 Anxiety disorders ................................................................................................. 36 
1.3.10 Age related predictors ........................................................................................ 37 
1.3.11 Summary ............................................................................................................ 37 
     iii 
1.3.12 Critique ............................................................................................................... 37 
1.4. Discussion .................................................................................................................. 39 
1.4.1 Limitations ........................................................................................................... 43 
1.4.2 Clinical implications ............................................................................................ 44 
1.4.3 Future Directions .................................................................................................. 45 
1.4.4 Conclusion ............................................................................................................ 45 
1.5 References .................................................................................................................. 46 
Chapter Two ............................................................................................................. 55 
The relationship between anxiety and intolerance of uncertainty in Cornelia de 
Lange and Fragile X syndrome .............................................................................. 55 
Abstract ..................................................................................................................... 56 
2.1 Introduction ............................................................................................................... 57 
2.1.1 ASD ...................................................................................................................... 57 
2.1.2 Intolerance of uncertainty .................................................................................... 58 
2.1.3 Cornelia de Lange syndrome ............................................................................... 61 
2.1. 4 Syndrome comparison group: ............................................................................. 63 
2.1.5 Rationale and Aims .............................................................................................. 64 
2.2 Method ........................................................................................................................ 65 
2.2.1 Ethical approval ................................................................................................... 65 
2.2.2 Recruitment .......................................................................................................... 65 
2.2.3 Participants ........................................................................................................... 65 
2.2.4 Procedure .............................................................................................................. 66 
2.2.5 Measures .............................................................................................................. 66 
2.2.6 A comment on measures of anxiety and intolerance of uncertainty .................... 69 
2.2.7 Data analysis ........................................................................................................ 69 
2.3 Results ......................................................................................................................... 71 
2.3.1 Comparing anxiety and intolerance of uncertainty between groups .................... 71 
2.3.2 Regression analyses ............................................................................................. 72 
2.3.3 Mediation analyses strategy ................................................................................. 74 
2.3.4 Mediation analyses ............................................................................................... 74 
2.4 Discussion ................................................................................................................... 77 
2.4.1 Limitations ........................................................................................................... 79 
2.4.2 Clinical implications and future directions .......................................................... 80 
2.5 References .................................................................................................................. 83 
Chapter Three: ......................................................................................................... 90 
     iv 
Detachment vs connection: reflecting on my identity as a researcher and 
clinician ..................................................................................................................... 90 
3.1 Introduction ............................................................................................................... 91 
3.2 Detachment ................................................................................................................ 91 
3.3 The importance of connection .................................................................................. 92 
3.4 Quantitative versus Qualitative methods ................................................................ 94 
3.5 Scientist- practitioner position ................................................................................. 96 
3.6 Conclusion .................................................................................................................. 98 
3.7 References .................................................................................................................. 99 
Appendices .............................................................................................................. 101 
Appendix A: ................................................................................................................... 101 
Appendix B ..................................................................................................................... 103 
Appendix C ..................................................................................................................... 104 
Appendix D ..................................................................................................................... 111 
Appendix E ..................................................................................................................... 113 
Appendix F ..................................................................................................................... 116 
Appendix G .................................................................................................................... 117 
Appendix H .................................................................................................................... 119 
Appendix I ...................................................................................................................... 121 
Appendix J ..................................................................................................................... 133 
Appendix K .................................................................................................................... 145 
Appendix L ..................................................................................................................... 149 
Appendix M .................................................................................................................... 154 
Appendix N ..................................................................................................................... 158 
Appendix O .................................................................................................................... 161 






     v 
List of Tables and Figures 
Tables Page 
Table 1.1 Key search terms used in the systematic literature review 6 
Table 1.2 Inclusion and exclusion criteria used when surveying the 
literature 
7 
Table 1.3 Checklist for assessing the quality of research as proposed by 
the CAT  
11 
Table 1.4 Key characteristics of studies 15 
Table 2.1 Comparing demographic information across participant 
groups 
70 
Table 2.2 ASC-ASD total scores, ADAMS general anxiety subscale 
scores and IUS-P total scores in CdLS and FXS 
71 
Table 2.3 The Hierarchical Linear Models for ASC-ASD and 
ADAMS-GA measures 
72 
Table 2.4 The direct and indirect effects of ASD symptoms on anxiety 
in CdLS and FXS. 
75 
Figures  
Figure 1.1 PRISMA flow diagram  10 
Figure 1.2 The evidenced predictors and relationships between 





     vi 
List of Abbreviations 
ASD Autism spectrum disorder 
ASC-ASD Anxiety Scale for Children with Autism 
Spectrum Disorder 
ADAMS-GA Anxiety, Depression and Mood Scale -
General anxiety subscale 
BASC-2 Behaviour Assessment System for 
Children (version 2) 
CASI-4/5 The Child and Adolescent Symptom 
Inventory 
CAT Critical Appraisal Tool 
CBT Cognitive Behavioural Therapy 
CdCS Cri du Chat syndrome 
CdLS Cornelia de Lange syndrome 
ClinPsyD Clinical Psychology Doctorate 
CUES Coping with Uncertainty in Everyday 
Situations 
COSIM Consensus Based Standards for the 
selection of Health Based Measurement 
Instruments 
DSM-5 Diagnostic and Statistical Manual 5 
DSM5-DAS Diagnostic and Statistical Manual 5, 
Dimensional Anxiety Scale 
EEG Electroencephalogram 
     vii 
FXS Fragile X syndrome 
IU Intolerance of Uncertainty 
IUS-P Intolerance of Uncertainty Scale- parent 
version 
MDT Multi-disciplinary team 
PhD Doctorate of Philosophy 
PRISMA Preferred Reporting Items for 
Systematic reviews and Meta-analyses 
PWP Psychological Wellbeing Practitioner 
RCMAS Revised Children’s Manifest Anxiety 
Scale 
SCARED Screen for Child Anxiety and Related 
Emotional Disorders 
SCAS Spence Child Anxiety Scale 
SRS-2 Social Responsiveness Scale -version 2 
TD Typically developing 
ToM Theory of Mind 
UK United Kingdom 
USA United States of America 
VABS Vineland Adaptive Behaviour Scale 
WS Williams syndrome 
  
 
     viii 
 
Acknowledgements 
First I must acknowledge the support, encouragement and valuable feedback from 
my supervisors Dr Eve Knight, Dr Tom Patterson, Dr Jo Moss and Prof. Chris 
Oliver. Eve and Tom, thank you for your suggestions, edits and support for the 
writing of this entire thesis. Jo, thank you for providing valuable feedback and 
thoughts about my empirical chapter design, analyses and write up. Chris, thank you 
for your support with the research design and for allowing me to collaborate with the 
team again. Thank you for starting me on this journey many years ago and for your 
inspirational commitment to working with people with intellectual disabilities and 
rare genetic syndromes.  
A huge thank you must go to the family support groups for CdLS and FXS, without 
whom this research could not have been conducted. Thank you to all the families 
who have taken part and for being so enthusiastic about the work done at the Cerebra 
Centre. 
I must also thank Laura Groves and Dr Hayley Crawford, with whom I collaborated 
in order to complete data collection for this thesis. Without Laura and Hayley, this 
work would not have been possible and I am very grateful for all your hard work and 
advice.  
I would like to thank my original cohort of trainees. I couldn’t have asked for a 
better group to train with and I have made lifelong friends. I look forward to joining 
you all on the other side of training and seeing where life takes us! I must also thank 
my ‘new’ cohort for being so welcoming and supportive during these final months of 
training and thesis writing. 
Finally, I would like to thank my family and friends for always supporting me and 
believing in me. In particular, my husband Stuart and our daughter Emily. Stuart has 
been a source of unwavering support and love throughout this process.  Emily was 
born halfway through my final year and so whilst not being particularly helpful in a 
practical sense, she has provided light relief when needed, has been an additional 
source of motivation and has also reminded me what is important. I hope one day she 
will be very proud of me.  
 
     ix 
 
Declaration 
This thesis has not been submitted for any other degree or to any other institution. 
This thesis was conducted under the academic and clinical supervision of Dr Eve 
Knight (Clinical Psychologist, Coventry University), Dr Tom Patterson (Clinical 
Psychologist, Coventry University), Dr Jo Moss (Research Fellow, University of 
Birmingham) and Professor Chris Oliver (Clinical Psychologist and Professor of 
Neurodevelopmental Disorders, University of Birmingham), all of whom were 
involved from the initial formulation of the research idea and design. All the material 
presented in this thesis is my own work. The data collection process was conducted 
as part of a collaboration with a larger research project at the Cerebra Centre for 
Neurodevelopmental Disorders at the University of Birmingham. The literature 
review and empirical paper are both written for submission to the Journal of Autism 
















     x 
Summary 
 
This thesis focusses on the issue of predicting anxiety in atypical populations, 
namely in autism spectrum disorder and in rare genetic syndromes.  
The first chapter presents a systematic review of quantitative research conducted 
with the aim of identifying predictors of anxiety in people with autism spectrum 
disorder. Nineteen papers were included in the review. A wide range of predictors 
were identified and organised into eight salient themes including social skills, 
cognitive skills, emotional regulation and physiological responses. Predictors were 
identified as being both as direct and through mediation. A critique of the reviewed 
studies is given. The review raised questions about the methodology typically used 
to assess anxiety in autism research and areas for future research are suggested. 
Chapter two presents a quantitative research study looking at the relationship 
between intolerance of uncertainty and anxiety in two rare genetic syndromes 
associated with autism spectrum disorder. Using questionnaire data, participants with 
Cornelia de Lange syndrome and Fragile X syndrome were compared on measures 
of anxiety, autism symptomatology and intolerance of uncertainty, and the 
relationships between these variables were examined. The findings of this study 
implicate intolerance of uncertainty in the presence of anxiety in both syndromes. In 
Cornelia de Lange syndrome, intolerance of uncertainty was found to mediate the 
relationship between autism symptoms and anxiety. Results are discussed in line 
with clinical and research implications.  
The final chapter is the author’s reflective account of conducting this research. The 
chapter reflects on the experience of conducting quantitative research as a trainee 
clinical psychologist and of managing the scientist-practitioner position whilst doing 
so. Reflections on the research process and the discovery of parallels with the 
author’s clinical work are also discussed.  
 
Overall word count when submitted: 17,144 
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Abstract 
Aim: This systematic review of quantitative research aimed to identify and 
summarise the key predictors of anxiety in autism spectrum disorders. Method: A 
literature search was conducted with PsychInfo, Medline, Embase and PubMed. 
Nineteen papers were identified which met the inclusion criteria of being 
quantitative and using analysis methods allowing for predictive relationships of 
anxiety in autism spectrum disorders to be identified. Findings: Several predictors 
were identified across the studies which were organised into key themes including 
cognitive skills, emotional regulation skills, physiological arousal, social skills and 
sensory sensitivities. Conclusion: The findings from this review highlight the 
complexity of relationships between predictors and anxiety in autism spectrum 
disorders. Inconsistencies in anxiety measurement and a reliance on parent-report 
across studies reveal methodological difficulties with investigating anxiety in people 
with autism spectrum disorders. Future work is needed to address these 
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1.1 Introduction 
Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterised by 
impairments in social communication and interaction and the presence of repetitive 
restricted behaviours as well as sensory sensitivities and/or sensory seeking 
behaviour (American Psychiatric Association, 2013).  The estimated prevalence of 
ASD in the United Kingdom (UK) is approximately 1% of the typically developing 
(TD) population (Simonoff et al., 2008).  
Whilst research initially focused on describing and understanding the core qualitative 
social and behavioural differences seen in ASD, more recently research has focused 
on the social and mental health needs of people with ASD (Hollocks, Lerh, Magiati, 
Meiser-Stedman, & Brugha, 2019). The delay in examining the relationship between 
anxiety and ASD may have been in part due to diagnostic overshadowing, whereby 
mental health difficulties are overlooked as they seem to be a feature of ASD (Mason 
& Scior, 2004). It has been debated whether symptoms such as high rigidity, social 
fear and unusual phobias are best explained as ASD or anxiety (Kerns et al., 2015). 
However, there is growing evidence for a strong association with anxiety disorders 
(which can be distinguished from core ASD symptoms; Renno & Wood, 2013) and 
several studies have investigated the prevalence and nature of anxiety in ASD.  
1.1.1 Anxiety in autism 
People with ASD are thought to be at an increased risk of developing mental health 
difficulties such as anxiety and depression (Joshi et al., 2013). Most research has 
focussed on these difficulties in children, as ASD was primarily considered to be a 
diagnosis of childhood. White, Oswald, Ollendick, and Scahill (2009) reported that 
generalised anxiety disorder, separation anxiety, social anxiety and phobias are the 
most commonly reported anxiety disorders in ASD. A meta-analysis examining the 
prevalence of anxiety in young people with ASD (aged under 18 years) indicated a 
prevalence of 39.6% of young people with ASD meeting criteria for an anxiety 
disorder diagnosis (Van Steensel, Bögels, & Perrin, 2011). This is higher than the 
prevalence rate in TD children (Costello, Egger, & Angold, 2005). Specific phobias, 
obsessive compulsive disorder (an anxiety-related condition) and social anxiety were 
most commonly reported. Another meta-analysis (van Steensel & Heeman, 2017) 
also showed anxiety levels to be higher compared to TD populations.  
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In adults, Hollocks et al. (2019) conducted a meta-analysis to examine rates of 
anxiety in adults (mean age 30.9 years, S.D= 6.2) with ASD. Across 30 studies, the 
combined estimates for current and lifetime prevalence for adults with ASD were 
between 27-42% for any anxiety disorder. This is higher than the prevalence rate in 
TD adults (approximately 7.2 %; Martín-Merino, Ruigómez, Wallander, Johansson, 
& García-Rodríguez, 2009). 
There is significant heterogeneity in the presentation of anxiety in ASD.  Research 
has reported various anxiety ‘symptoms’ including; fears of loud sounds, unusual 
phobias, debilitating social avoidance, social distress, excessive worry around 
change and highly rigid behaviours (Kerns & Kendall, 2012). Kerns et al. (2015) 
suggested that individuals with ASD can present with both ‘traditional’ anxiety 
symptoms (consistent with the DSM 5) and also atypical anxiety which does not fit 
with DSM-5 defined categories but presents as ‘exacerbated and clinically impairing 
anxiety around the hallmark features of ASD’ (Kerns et al., 2015). The authors 
examined anxiety presentations in fifty-nine children with ASD and assessed anxiety 
as ‘traditional’ or ‘atypical’. Seventeen percent of participants had traditional 
presentations, 15% atypical and 31% presented with both traditional and atypical 
anxiety.  
1.1.2 Impact of anxiety 
The impact of anxiety on people with ASD has been widely reported. Chang et al. 
(2012) suggested anxiety interferes with everyday functioning and impacts on people 
with ASD’s ability to interact with others. Wood and Gadow (2010) suggested that 
anxiety may be a moderator of social skills and repetitive behaviours. Research has 
demonstrated an association between anxiety in ASD and both increased parental 
stress and lower family functioning (Kerns et al., 2015; Rao & Beidel, 2009).  Kim, 
Szatmari, Bryson, Streiner, and Wilson (2000) demonstrated that anxiety in ASD is 
associated with negative family outcomes (parent-child relationships) and a limited 
ability to participate in social activities. Kerns et al. (2015) found that young people 
with ASD were more likely to display self-injurious behaviour and that parents 
reported higher levels of stress than parents of children with ASD but no anxiety.  
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1.1.3 Factors associated with anxiety 
Research has identified many different variables associated with anxiety in ASD.  
Gadow, DeVincent, and Schneider (2008) examined the associations between 
demographic variables and anxiety in ASD and found associations with common 
demographic risk factors such as age, IQ, family psychiatric history and early 
intervention with anxiety.  
 In a parental focus group aimed at furthering understanding of anxiety presentations 
in ASD, Ozsivadjian, Knott, and Magiati (2012) interviewed 17 mothers of children 
with ASD. The parents identified factors such as changes to routine, specific 
phobias, sensory sensitivities and too many demands as being triggers of anxiety for 
their children.  
Several studies have found associations between core deficits and anxiety in ASD. 
For example, assertiveness, social skills (Chang et al., 2012) communication 
difficulties, theory of mind deficits (Burnette et al., 2005), maladaptive thinking 
styles (Sharma, Woolfson, & Hunter, 2014) and intolerance of uncertainty (Boulter, 
Freeston, South, & Rodgers, 2014). Whilst some studies have conducted analyses to 
allow the predictive power of these variables on anxiety to be determined, many of 
these studies have simply explored correlations between anxiety and other variables, 
and so causal links cannot be made.  
1.1.4 Rationale 
Research has demonstrated a high prevalence of anxiety disorders in people with 
ASD and many studies have reported on the impact of this anxiety on everyday life, 
family stress, social skills and emotional wellbeing for people with ASD. Individual 
studies have highlighted associations between different variables and anxiety such as 
sensory sensitivity (Green & Ben-Sasson, 2010) ASD symptom severity (Mayes, 
Calhoun, Murray, & Zahid, 2011) and theory of mind skills (Burnette et al., 2005). 
Reviews such as van Steensel and Heeman (2017) and Hollocks et al. (2019) have 
reported on the prevalence of anxiety disorders in ASD but to date, no review has 
synthesised research regarding the different predictors of anxiety symptomatology in 
ASD. There is a need to understand and summarise the literature which demonstrates 
predictive relationships between certain variables and anxiety symptomatology. 
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Once predictors have been identified, they can point to potential intervention 
strategies to reduce anxiety symptoms in people with ASD and improve quality of 
life.  
1.1.5 Aims 
The aim of this literature review was to systematically review research investigating 
the predictors of anxiety symptomatology in people with ASD, in order to answer 
the research question “What are the key predictors of anxiety in ASD?” 
1.2 Method 
1.2.1 Literature Search 
A systematic search of the literature was conducted for research investigating what 
factors predict anxiety in people with ASD. Ethical approval to conduct this review 
was granted by the University of Coventry Ethics Committee (Appendix B). Table 
1.1 outlines the key search terms used.  
Table 1.1. Key search terms used in the systematic literature review 
Main concept Synonyms Location 
Participants with ASD  autism*OR autis* OR 
autistic* OR ASD OR 
'autism spectrum disorder' 
OR PDDNOS OR PDD-
NOS OR 'pervasive 
developmental disorder 
not otherwise specified' 
OR Asperger*OR 




Anxiety anxi*OR anxious* OR 
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Predictors predict* OR predictor OR 
factor OR correla* OR 





Literature searches took place between February and March 2019 and focussed on 
the most relevant databases covering literature in psychology and medical science. 
The databases searched included PsychInfo, Medline, Embase and PubMed. A 
manual search was conducted of the reference list of extracted articles. 
1.2.2 Inclusion and Exclusion Criteria 
Table 1.2 Inclusion and exclusion criteria used when surveying the literature 
Criteria Include Exclude 
Language English Non-English 
Study type Quantitative 









Participants with ASD and 
comorbid intellectual 
disability, rare genetic 
syndromes and additional 
neurodevelopmental 
disorders such as ADHD 
 
Diagnosis A confirmed diagnosis of 
ASD (either by previous 
psychiatrist/psychologist 
No confirmed diagnosis of 
ASD.  
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assessment or using a 
validated measure such as 
the ADOS or questionnaire 
measure) 
 
Anxiety measure Validated measure of 
anxiety or validated 
measure with an anxiety 
subscale included. 
 
No validated measure of 
anxiety 
Analysis Analysis allowing 
conclusions about 
predictive nature of 
variables on anxiety- i.e. 
Regression analysis, 
Structural equation 




No predictors of anxiety 
found/identified.   
 
At the screening stage, titles and abstracts were reviewed (and where necessary full 
texts) to ensure they met the review’s inclusion and exclusion criteria. The 
parameters for inclusion and exclusion are outlined in Table 1.2.  The initial 
fundamental characteristics were that papers were in English, were peer-reviewed 
and accessible to review.  
Following initial screening, full-text articles were obtained and further assessed for 
eligibility to be included in the review. This review was concerned with the 
predictors of anxiety in ASD. Therefore, articles were excluded if their analysis did 
not allow for conclusions to be drawn about whether a variable is predicting anxiety 
in their participants. Several studies conducting only correlation analyses were not 
included in this review as the analyses did not allow identification of predictor 
variables. Due to the range of anxiety disorders associated with ASD, it was decided 
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that studies exploring the predictors of any anxiety disorder (including generalised 
anxiety, specific phobias, and social anxiety disorder) should be included to widen 
the scope of the search. Studies exploring predictors of obsessive compulsive 
disorder (OCD) were not initially excluded. OCD is no longer categorised as an 
anxiety disorder in the DSM-V (APA, 2013) and is now considered an anxiety-
related condition instead.  However, no studies included in the final review examined 
predictors of OCD.   
Whilst most literature has focussed on anxiety in children with ASD, studies were 
included regardless of participant age, on the basis that studies with adults may 
highlight different clinically relevant predictors of anxiety. 
1.2.3 Classification of Studies 
As outlined by Moher et al. (2015), the process of study selection for this review was 
recorded on a ‘Preferred Reporting Items for Systematic Reviews and Meta-
Analyses’ (PRISMA) flow diagram (see Figure 1.1). In total 3931 articles were 
initially identified following searches in PsychInfo, Medline, Embase and PubMed 
and manual searches of the reference lists of included studies. After removal of 
duplicates, 1928 articles remained. Following a review of title and abstracts against 
the inclusion and exclusion criteria, 1870 articles were excluded as not relevant. The 
majority of these papers were excluded due to methodological reasons such as 
studies being qualitative or case study designs or studies looking at predictors of 
anxiety in parents of children with ASD, rather than children with ASD themselves.  
 The full text for the 58 remaining articles were reviewed and a further 39 articles 
were excluded. Reasons for exclusion included conducting correlation analysis only, 
not using a sample with a confirmed ASD diagnosis or using sample populations 
with comorbidities such as intellectual disability or ADHD.  
Following a search of the literature, a total of 19 studies met the inclusion criteria 
and so were retained for systematic review.  
 
 

























Figure 1.1 PRISMA flow diagram (Moher et al. 2015) 
Records identified through 
database searching (n=3919) 
Additional records identified 
through manual searches of 
reference lists (n=12) 
Total number screened for 
duplicates (n=3931) 
Abstracts screened (n=1928) Records excluded 
(n=1870) 
Full text articles assessed for 
eligibility (n=58) 
Full text articles excluded 
(n=39) 
Reasons for exclusion 
1. Autistic traits not 
ASD, n=5 
2. Correlation analysis 
n=7 
3. Looked at what 
anxiety predicts n=8 
4. Conference abstract 
only n=5 
5. No predictor found 
n=2 
6. No anxiety measure 
used n=3 
7. Participants had 
comorbidities n=6 
8. Review articles n=2 
9. Looked at mothers 
of children with 
ASD n=1  
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1.2.4 Quality Assessment 
In order to assess the quality of the 19 studies identified from the systematic review 
process, the Critical Appraisal Tool developed by Crowe and Sheppard (2011) was 
used. This framework was considered suitable for the current review because it can 
be applied to quantitative research methodologies and has undergone reliability and 
validity testing (Crowe, 2013). 
The CAT is divided into eight categories and 22 items in total. Each category has a 
multiple item description to aid appraisal and scoring of each category. The lowest 
score an article can achieve in a category is 0 and 5 is the highest. Half marks are not 
permitted. Total scores are calculated out of 40 (with a higher score indicating higher 
quality). Table 1.3 gives an overview of the categories and items included in the 
CAT. The CAT comes with a user guide and guidance questions for each category to 
aid scoring.  
Table 1.3. Checklist for assessing the quality of research as proposed by the CAT 
(Crowe, 2013) 






Design Research design 
Intervention, treatment, exposure 
Outcome, output, predictor, measure 
Bias 
Sampling Sampling method 
     12 
Sample size 
Sample protocol 
Data collection Collection method 
Collection protocol 
Ethical matters Participant ethics 
Researcher ethics 
Results Analysis, integration, interpretation 
method 
Essential analysis 




Total score  
 
To enhance the reliability of the quality assessment, another researcher rated 10 out 
of the 19 articles independently using the CAT framework. Large disagreements in 
scores were discussed and rating consensus was reached. Inter-rater reliability 
analysis using intra-class correlation coefficients (ICC) as outlined in the CAT user 
guide (Crowe, 2013) were use. ICC scores ranged from 0.997 to 1 and indicate 
excellent inter-rater reliability.   
12 studies out of 19 resulted in an above average score on the quality assessment 
framework.  All studies assessed had a higher quality score than the midline cut off 
(20/40). The lowest quality score was given to one paper (Bellini, 2006) receiving 
24/40, the highest score was given to one paper (Bitsika, Arnold & Sharoley, 2019) 
scoring 38/40. Overall all studies were relevant to the review and sufficiently 
described their aim. All papers carried out appropriate statistical analyses and 
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reported the results sufficiently. Areas of lower quality were in the studies’ reporting 
of ethical considerations and in the description of sampling and data collection 
methods. Many studies did not provide sufficient information in these areas to allow 
for replication.  
1.2.5 Characteristics of Studies 
A summary of the key characteristics of the 19 studies included in this review can be 
found in Table 1.4. All studies had similar aims, to investigate and describe 
relationships between anxiety and potential contributing factors. 
The majority of the studies were conducted in the USA (nine), two studies (Boulter 
et al., 2014; Maisel et al., 2016) were a joint project with research sites in the USA 
and UK. Two studies (Hollocks, Pickles, Howlin & Simonoff,  2016; Palser, 
Fotopoulou, Pellicano & Kilner, 2018)  were conducted solely in the UK, one was 
conducted in Canada (Kim et al., 2000) and four were conducted in Australia 
(Bitskia & Sharpley, 2018; Bitsika. Arnold & Sharpley, 2019; Cai. Richdale, 
Dissanay, Uljarevic, 2019;  Uljarevic, Richdale, Evans, Cai, Leekam, 2017).  
Of the 19 studies identified for review, 16 were carried out between 2010 and 2019, 
and the remaining three (Bellini, 2006; Gadow et al., 2008; Kim et al., 2000) were 
carried out post 2000. Eighteen studies used a cross-sectional design, one study 
(Neuhaus et al., 2016) used a longitudinal design comparing anxiety measures at 
time 1 and time 2.   
Only five studies (Cai et al, 2018; Miasel et al., 2016; Swain, Scarpa, White & 
Laugeson, 2015; Uljraevic et al, 2017;  Wallace et al., 2016) used adult participants 
(mean age over 18 years). 15 studies used sample sizes of over 50 participants. The 
smallest sample size was 23 participants (Neuhaus et al., 2016) and the largest was 
2662 (Dubin, Lieberman-Betz, & Lease, 2015). All studies used questionnaire 
measures of anxiety, and all studies used anxiety measures that were validated in the 
general population but were not ASD specific measures of anxiety. One study used 
EEG to map neural responses with anxiety.  
Across the 19 studies in this review, 17 different anxiety measures were used. These 
were:  
• Adult Behaviour Checklist (Achenbach & Rescorla, 2003) 
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• Behaviour Assessment System for Children -2 (Reynolds & Kamphaus, 
2004) 
• Child Behaviour Checklist (Achenbach, 1999) 
• The Child and Adolescent Psychiatric Assessment (Angold & Costello, 
2000) 
• The Child and Adolescent Symptom Inventory- 4 (Gadow & Sprafkin, 1997) 
• The Child and Adolescent Symptom Inventory- 5 (Gadow & Sprafkin, 1997) 
(Sukhodolsky et al., 2008) 
• DSM-5 Dimensional Anxiety Scales (Knappe et al., 2013) 
• Fear of Negative Evaluation- Brief (Leary, 1983) 
• Negative affectivity self statement questionnaire (Ronan, Kendall, & Rowe, 
1994) 
• Penn State Worry Questionnaire (Meyer, Miller, Metzger, & Borkovec, 
1990) 
• Pediatric Behaviour Scale (Lindgren & Koeppl, 1987) 
• Revised Children’s Manifest Anxiety Scale (Reynolds & Richmond, 1997) 
• Revised Ontario Child Health Study (Boyle et al., 1993) 
• Screen for Child Anxiety and Related Emotional Disorders (Monga et al., 
2000) 
• Social Anxiety Scale for Adolescents (La Greca, 1999) 
• Spence Chidren’s Anxiety Scale (Nauta et al., 2004; Spence, 1998) 
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Social skills deficits of 
Assertion (B= -1.68, SEB= 0.52, 
p=.003) and Empathy (B= -
13.348, SEB= 4.547, p=.006) 
combined with elevated 
physiological arousal (B= 0.52, 
SEB= 0.16, p=.002) 
significantly contributed to 
variance in social anxiety 

























90 boys with 
ASD 













































Higher scores in matrix 
reasoning were associated with 
lower separation anxiety scores, 
while higher social motivation 
were associated with higher 
separation anxiety. Matrix 
reasoning (R2=.09, F(1, 87) for 
change = 8.85, p=.004) 
combined with Social 
motivation (R2 =.17, F(1, 86) for 
change = 8.08, p=.006) 























disorder in young 






























Sensory avoidance mediated the 
relationship between ASD and 
(parent rated) anxiety scores 
(Total effect B=0.46, t= 6.02, 
p<.001) Indirect effect B= 0.33 














anxiety exists in 



































Intolerance of uncertainty is 
mediating the relationship 
between ASD and anxiety (in 
both parent and child report 
data). 
Main effect of IU 

































































All key variables were 
associated with each other. 
Intolerance of uncertainty 
mediated the relationship 
between emotional regulation 
and anxiety symptoms  
(Total effect B=8.29, p<.002) 
Indirect effect B= 5.00 (95% CI 
1.92, 9.37) 













































Increases in age, (B= 0.10, 
SEB= .01, p<.001) social 
withdrawal (B= 0.07 SEB= .00, 
p=<.001) and increased 
cognitive functioning (B=0.67 
SEB= .0.11, p<.001) predicted 














































GAD early intervention (r=-.15, 
p<0.05, attending a special 
school (r=-.28, B= -0.21,  
p<.05), ever hospitalized (r=.17, 
B= -0.14,  p<.05), family 
psychiatric history(r=.30, 
B=0.18 ,  p<.05) predicted the 
presence of anxiety. 
















p<.05) gender (r=-.16, B=-0.15 , 
p<.05) early intervention (r=-
.20, B= -0.19,  p<.05), 
pregnancy complications (r=.19, 
B= 0.19,  p<.05), attending a 
special school (r=-.15, p<.05) 
predicted the presence of 
anxiety. 
SAD Age, (r=-0.17, B=-.14 ,  
p<.05) pregnancy complications 
(r=.22, B= .16,  p<.05, family 
psychiatric history(r=.23, B= 
.16,  p<.05) predicted the 


































responsiveness (B= -0.70, 
p<.01) and greater attentional 
bias (B= -0.37, p<.01) both 
predicted anxiety in ASD.   
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processing biases 






 SCAS-C and 
SCAS-P 







pathways and were not inter-
related.  
Full model (X2 (7)=6.4, CFI= 






































Anxious cognitive style (B= -
0.32, t=2.49, p=.002) sensory 
hypersensitivity (B= 0.33, t= 
2.61, p= .01) and language 
ability (B= 0.43, t= 2.42, p=.02) 
predicted ‘traditional’ 
(consistent with DSM-5) 
anxiety.  
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p=.003) and anxious cognitive 
style (B= 0.28, t=2.08 p=.04) 








To report on the 
prevalence and 
correlates of 





























The only variable to predict 
anxiety scores was the 
discrepancy score between 
verbal and non verbal ability 
(B= 9.83 p=.0003). Children 
with high verbal than non verbal 












To examine the 
relationship 
between theory 
of mind skills 






























Broad social impairment 
significantly predicted anxiety 
scores (B= 0.25 SEB= .0.05, 
p=<.001).  General theory of 
mind skills did not predict 
anxiety, but early theory of 
mind competency mediated the 
relationship between broad 
social impairment and anxiety.  
Suggests that underlying 
common deficits in social skills 
and anxiety may be driven by 
specific set of skills rather than 
TOM deficits in general.  
Total effect R2=0.64, p<.001 











To model the 
contributions of 








Structural equation modelling 







































for intolerance of uncertainty, 
alexithymia and emotional 
acceptance predicting anxiety in 
people with ASD, independent 
of ASD symptoms severity. (X2 
(12) = 13.89, CFI= .998, 
RMSEA=0.02, p=.381) 
Mediation analysis showed 
intolerance of uncertainty 
alexithymia and emotional 
acceptance almost entirely 
mediating the relationship 




















Of the various demographic 
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(2011)  variables 
associated with 
anxiety in ASD 














analysis regression analyses, increasing 
autism severity was the best 
predictor of anxiety (B= 0.31, 
t=8.7 p=<.0001). The best 
combined predictors were 
autism severity, verbal IQ and 














































Slower face processing during 
early childhood predicted self-
reported anxiety scores in 
adolescence (r=0.84, p<.01). 
This is consistent with 
suggestions that basic face 
processing is the foundation for 
more complex social 
communication skills 


















and aggression)  















































In pre-school children a 
combination of high aggression 
(B=.024, SEB= .09, p<.01) and 
high social understanding 
(B=0.53, SEB= .10,  p<.001)  


















(Nauta et al., 




A multiple regression analysis 
































analysis relative contributions of 
interoceptive accuracy, 
sensibility and ASD symptoms 
to anxiety. Interoceptive 
sensibility was the only 
significant predictor of anxiety 







To test a model 








69 adults with 
ASD 


















Emotion dysregulation (B= 
0.22, p<.05 parent report, 
B=0.60, p<.001 child report) 
and social motivation (B=0. 57, 
p<.001 parent report, B=0.24, 
p<.05 child report) significantly 
predicted social anxiety. 
When subscales of the 
‘Difficulties of emotional 
regulation’ measure were 
entered as predictor variables, 
difficulties with goal directed 
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(B= 0.25, p<.05), lack of 
awareness of emotions (B= 
0.24, p<.05), and social 
motivation (B= 0.53, p<.001) 
significantly predicted care-
giver reported anxiety.  
For self reported anxiety, 
predictors were non acceptance 
of negative thoughts (B= 0.29, 
p<.05), difficulties with goal 
directed behavior (B= 0.26, 
p<.05), impulse control 
difficulties with negative 
emotions(B=0 .36, p<.01),  and 
limited access to strategies for 
emotional regulation (B= 0.51, 

























































Insistence on sameness was 
associated with effortful control 
and anxiety. Anxiety was 
associated with effortful control.  
Mediation analyses showed 
insistence on sameness 
mediating the relationship 
between effortful control (self 
regulation) and anxiety. (B= -
0.06, 95% CI -.13, -.02) A 
second mediation model also 
showed effortful control 
mediating the relationship 
between insistence on sameness 
and anxiety (B= 1.62, 95% CI 




















and anxiety and 
depression in 
ASD 


























Neither age nor IQ significantly 
predicted anxiety or depression. 
Shifting skills was the only 
significant predictor of anxiety 
symptomatology (F=8.56, p= 
.022, R2= .38).  More executive 
function problems were 
associated with greater 
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1.3 Results 
Across the 19 studies included in this review, several unique predictors of anxiety in 
ASD were identified. These predictors can be organised into key concepts of: 
• Social skills and behaviour 
• Sensory sensitivities 
• Cognitive and executive related skills 
• Emotional regulation and awareness 
• Physiological arousal 
• Language ability 
• Demographic variables 
• Face processing 
A summary of all the studies included in this review is outlined in Table 1.4. The 
salient findings for each of the key concepts will now be summarised. 
1.3.1 Social skills and behaviour 
Six studies identified social skills-related factors to be predictive of anxiety in ASD, 
however the exact ‘social skills’ deficits varied across the studies. Bellini (2006) 
used the Assertion and Empathy subscales from the Social Skills Rating System 
(Gresham & Elliott, 1990) as these constructs are believed to be significantly 
impaired in people with ASD. The ‘Assertion’ subscale measures behaviours which 
initiate social interaction while the ‘Empathy’ subscale measures behaviours which 
demonstrate concern for others and respect for others’ feelings. Using multiple 
regression analysis, the authors found that Assertiveness and Empathy scores were 
significant predictors of social anxiety (alongside increased physiological arousal). 
The authors suggested that their results support a proposed developmental pathway 
in which higher physiological arousal increases likelihood of social withdrawal, 
which impedes social skills development. Social skills deficits then increase the 
likelihood of negative social experiences with peers which increases social anxiety 
and leads to further withdrawal. Bitsika and Sharpley (2018) found that social 
motivation (and matrix reasoning skills) is a significant predictor of separation 
anxiety (from parents) in boys with ASD using the Social Motivation subscale of the 
Social Responsiveness Scale (SRS 2) (Constantino & Gruber, 2012). Bitsika and 
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Sharpley (2018) hypothesised that a lack of understanding about the link between 
reduced social interaction and loneliness may lead to increased seeking of parental 
presence as compensation. This could then result in increased separation anxiety. 
Swain et al. (2015) also used the SRS2 to look at the relationship between social 
motivation, emotional regulation and social anxiety. They found that reduced social 
motivation significantly predicted higher levels of social anxiety (caregiver 
reported). Dubin et al. (2015) found that social withdrawal predicted higher parent-
reported anxiety in children with ASD. Niditch et al. (2012) found that social 
understanding (and aggression) (measured from the social skills subscale on the 
BASC-2; Reynolds & Kamphaus, 2004)) predicted anxiety in preschool aged 
children.   
Lei and Ventola (2018) examined the role of theory of mind (ToM) skills 
specifically. The authors found that early ToM skills deficits mediated the 
relationship between social communication impairments and anxiety. These authors 
suggested that early ToM skills underpin components of social functioning which 
may also underlie anxiety in children with ASD.   
The studies by Dubin et al. (2015), Bitsika and Sharpley (2018), Niditch et al. (2012) 
and Lei and Ventola (2018) scored particularly highly on the quality assessment 
rating (scores between 32 to 35) which indicates they were methodologically robust 
and strongly implicates social skills and behaviour in predicting anxiety in ASD.  
1.3.2 Sensory sensitivities 
Three studies found sensory sensitivities to be predictive of anxiety in ASD. Bitsika 
et al. (2019) used the Sensory Profile (Dunn, 1999) to measure participants’ 
responses to sensory events. Sensory responses can be divided into ‘low 
registration’, ‘sensory seeking’, ‘sensory sensitivity’ and ‘sensory avoidance’. 
Results showed that sensory avoidance mediated the relationship between autism 
symptomatology and anxiety (parent rated). No other sensory behaviours predicted 
anxiety. Kerns et al. (2014) also used the Sensory Profile and found that sensory 
sensitivity and sensory avoidance predicted ‘traditional’ anxiety symptoms in 
children with ASD.  
Palser et al. (2018) investigated the role of interoception - the detection of the 
physiological state of the body, a type of sensory processing. Palser et al. (2018) 
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found that interoceptive sensibility (how aware an individual is of internal bodily 
signals) predicted anxiety in children and adolescents in ASD.  The authors 
suggested that the more an individual is aware of their interoceptive sensations, the 
higher their anxiety because they engage in cognitive appraisal of these sensations 
with cognitions that are negatively biased and sensations are interpreted as 
threatening.  
The studies by Bitsika et al. (2019) and Palser et al. (2018) were the highest quality 
rated studies in this review. This suggests the studies were highly methodologically 
robust and provides additional support that sensory sensitivities can predict anxiety 
in ASD.  
1.3.3 Cognitive and executive related skills 
Eight studies found cognitive factors to be predictors of anxiety, including executive 
function skills, anxious cognitive styles and intolerance of uncertainty. Boulter et al. 
(2014), Maisel et al. (2016) and Cai et al. (2018) found that ‘intolerance of 
uncertainty’ significantly predicted anxiety in people with ASD. Boulter et al. (2014) 
found that intolerance of uncertainty fully mediated the relationship between ASD 
symptomatology and anxiety in their participants which was consistent with findings 
from the TD population.  
Intolerance of uncertainty is a construct associated with anxiety in both TD and 
atypical populations and is a ‘broad dispositional risk factor’ in the ‘development 
and maintenance of clinically significant anxiety’ in neuro-typical populations 
(Carleton et al., 2012, p. 939). Boulter et al. (2014) concluded that intolerance of 
uncertainty is a key construct in understanding the relationship between ASD 
symptomatology and anxiety in children with ASD.  
Hollocks et al. (2016) examined both cognitive and biological factors predicting 
anxiety in ASD. They found that attentional biases towards threat significantly 
predicted anxiety in ASD. Attentional biases are common in childhood anxiety 
disorders (Bögels, Snieder, & Kindt, 2003) and the authors suggested that targeting 
cognitive differences such as attentional biases may be effective intervention for 
anxiety in ASD.  
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Wallace et al. (2016) investigated the relationship between executive function 
deficits and anxiety in ASD using the Behaviour Rating Inventory of Executive 
Functioning (Gioia, Isquith, Guy, & Kenworthy, 2000) questionnaire measure; they 
found that difficulties with cognitive flexibility predicted anxiety symptoms in their 
sample. 
1.3.4 Emotional regulation and awareness 
Four studies found that emotional regulation skills and/or awareness predicted 
anxiety in their participants. For example, Maisel et al. (2016) examined the 
relationships between emotional acceptance, alexithymia, intolerance of uncertainty 
and anxiety in adults.  They found that alexithymia and emotional acceptance 
mediated the relationship between ASD symptomatology and anxiety. The authors 
concluded that people with ASD experience higher levels of anxiety because they 
are more likely to react negatively to their emotional experiences (decreased 
emotional acceptance) while also being less able to identify and understand their 
emotions (alexithymia).  They suggested that interventions which increase emotional 
acceptance may be helpful in treating anxiety in ASD. Swain et al. (2015) found that 
in adults with ASD, emotional dysregulation measured by the Difficulties in 
Emotion Regulation Scale (Gratz & Roemer, 2004; and social motivation) predicted 
anxiety symptoms. Specific subscales on this measure; difficulties with goal directed 
behaviour for negative emotions, lack of emotional awareness and limited emotional 
regulation strategies were significant predictors of anxiety.  
1.3.5 Physiological arousal 
Two studies identified physiological arousal as a predictor of anxiety. However, the 
studies produced diverging results. 
Hollocks et al. (2016) assessed physiological arousal with a ‘stress test’ whereby 
participants were exposed to stressful situations (copying a complex drawing, 
preparing a presentation, giving a speech and remembering the drawing) before 
having a 40-minute relaxation period, Biological measures of stress such as salivary 
cortisol and heart rate were taken and analysed throughout the task and the relaxation 
session. These physiological data were analysed and compared to scores on a 
questionnaire-based mental health assessment that also measured anxiety. The 
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authors found a significantly blunted heart rate and cortisol response (reduced 
physiological responsiveness) significantly predicted higher anxiety scores. Hollocks 
et al. (2016) suggested further research is needed to understand the mechanism by 
which physiological under-responsiveness is related to anxiety. They suggested that 
it may be related to exposure to chronic stress over the course of childhood which 
leads to this blunting of physiological responses.  
Bellini (2006) also found an association between anxiety and physiological arousal, 
however the study did not use a direct measure of physiological arousal, rather they 
used the Multidimensional Anxiety Measure (March & Parker, 2004) (questionnaire 
measure) and used the ‘Physical symptoms’ scale which details different 
physiological symptoms of anxiety. The authors found that elevated physiological 
arousal was related to higher levels of social anxiety.  
Comparing the quality ratings between these studies shows that the Hollocks et al. 
(2016) study received one of the highest ratings in this review (37) with high ratings 
relating to methodology and results whereas the Bellini (2006) paper received the 
lowest (24), with lowest ratings in the research design and results section of the 
paper. The findings from the Hollocks et al (2016) study could therefore be 
considered more robust in the context of these diverging results.  
1.3.6 Language ability 
Two studies suggested a predictive association between language ability and anxiety 
in ASD. Using hierarchical regression, Kerns et al. (2014)) found that stronger 
language ability was associated with higher levels of ‘traditional’ (consistent with 
the DSM-5) anxiety symptoms in children with ASD. Kim et al. (2000) found that 
children with a larger discrepancy between verbal and non-verbal IQ scores had 
higher anxiety symptoms, although this effect was small and the authors reported the 
mechanism for this difference is unclear.  
1.3.7 Demographic variables 
Three studies included analysis of common demographic risk factors for the 
development of anxiety in ASD (Gadow et al., 2008; Kerns et al., 2014; Mayes et al., 
2011). Factors such as IQ, age, autism severity, and parental anxiety were found to 
predict higher anxiety scores in children with ASD. However, Gadow et al. (2008) 
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acknowledged that (whilst significant) the strength of the relationship was weak for 
many of the predictors identified in their study and suggested more research is 
needed to identify additional variables which could be risk factors for anxiety. 
Anxiety scores were not related to gender in any of the three studies. This is 
consistent with other studies (Hurtig et al., 2009; Sukhodolsky et al., 2008)  
1.3.8 Face processing 
Neuhaus et al. (2016) examined the relationships between autism symptom severity, 
anxiety and neural face processing responses using EEG in 26 children and 
longitudinal measures of anxiety and ASD symptomatology. They found that slower 
processing of neutral faces at aged 3 predicted higher self-reported anxiety 
symptoms in adolescence. Slower face processing was also related to higher levels of 
ASD symptomatology at adolescence. They concluded that the best outcomes for 
social behaviour and anxiety are associated with the ability to process faces quickly 
and to distinguish between neutral and negative facial expressions effectively. They 
also argued that slow face processing as a shared predictor of both anxiety and ASD 
symptomatology was not surprising as both rely on early brain development and 
functioning.  
1.3.9 Anxiety disorders 
Across the nineteen studies included in the review, 15 looked at predictors of GAD 
three looked at social anxiety (Bellini, 2006; Bitsika & Sharpley, 2018; Swain et al., 
2015)  one included specific phobias (Gadow et al., 2008) and three looked at 
separation anxiety (Bitsika & Sharpley, 2018; Gadow et al., 2008; Kim et al., 2000). 
The studies examining social anxiety and separation anxiety found predictors related 
to social skills such as social motivation, as well as emotional dysregulation. The 
only study investigating specific phobias (Gadow et al., 2008)  was focused on 
demographic variables and so a range of relevant predictors may have been missed. 
The fifteen studies investigating predictors of GAD found a range of predictors 
including sensory sensitivities, cognitive skills, social skills, verbal ability, 
intolerance of uncertainty, age and emotional regulation.  
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1.3.10 Age related predictors 
Only five studies used adult participants, (Cai et al., 2018; Maisel et al., 2016; Swain 
et al., 2015; Uljraevic et al., 2017;  Wallace et al., 2016) therefore it is not possible to 
comment on whether all predictors are consistent for both adults and children with 
ASD. However, of the studies including adults, predictors found were in line with 
the findings in children. For example, intolerance of uncertainty, emotional 
regulation and social motivation were predictors identified in studies using either 
children or adults with ASD. This suggests similar mechanisms may be underlying 
anxiety across the lifespan. Further investigation and comparison is needed to 
determine if this is true for all predictors identified in this review.  
1.3.11 Summary 
Across nineteen studies, several predictors and mediators of anxiety were identified. 
All but one predictor (face processing ability) were identified in multiple studies. 
The predictors identified were synthesised into key themes which included social 
skills, sensory sensitivities, cognitive skills, emotional regulation skills, 
physiological arousal, language ability, face processing skills and demographic 
variables such as IQ, age and autism severity.  In terms of clinical utility, the most 
significant predictors identified were executive function and emotional regulation 
skills as arguably these are variables which could be targeted for intervention.  
1.3.12 Critique 
All the studies included in this review gained a quality assessment score of 24 and 
above out of 40. The average score for quality assessment was 32, therefore these 
papers were of a high quality across a number of domains on the CAT (Crowe, 
2013). All the studies included provided confirmation of a diagnosis of ASD, both 
using previous clinical diagnosis from professionals and also using either direct 
assessment such as the Autism Diagnostic Observation Scale (Pruette, 2013) or 
questionnaire measures such as the Autism Quotient (Auyeung, Baron-Cohen, 
Wheelwright, & Allison, 2008). This means that the findings of this review can be 
generalised to the ASD population.  However, given the potential of the results of 
these papers to inform interventions for anxiety in ASD, it is important to consider 
the limitations of the studies when evaluating the findings. The key limitations 
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across the studies were the use of parent report measures of anxiety, that the majority 
of studies used child samples, that all but one study used a cross-sectional design and 
the use of a variety of different anxiety measures across the studies that have not 
been validated for use with an ASD population. 
Nine papers used solely parent report to measure anxiety in their ASD samples 
(Dubin et al., 2015; Gadow et al., 2008; Hollocks et al., 2016; Kerns et al., 2014; 
Kim et al., 2000; Lei & Ventola, 2018; Mayes et al., 2011; Niditch et al., 2012; 
Wallace et al., 2016). Three studies used both parent and child report measures 
(Bellini, 2006; Bitsika et al., 2019; Boulter et al., 2014). In the Van Steensel et al. 
(2011) meta-analysis of 31 studies of anxiety in children with ASD, they found that 
parent-report measures were the dominant methodological strategy. While parent-
report is common in ASD research, research suggests parents underestimate the 
frequency of internal anxiety symptoms in their children, and parent-child agreement 
is low for these internal experiences (Cantwell, Lewinsohn, Rohde, & Seeley, 1997).  
Logically, it follows that ratings may be different because parents can report on what 
they see in their child, whereas the child can report on what they feel inside. 
However, some studies have found high levels of agreement between parent and 
child reporting of anxiety (Ozsivadjian, Hibberd, & Hollocks, 2014). Of the studies 
reviewed here, Bitsika et al. (2019) used both parent and child report measures and 
found differences in how the parent and child ratings mapped on to other behaviours. 
In contrast, Boulter et al. (2014) found the same relationships between anxiety 
(whether child or parent reported) with other variables. Bitsika et al. (2019) 
suggested that both parent and child report ratings, while different, may be equally 
valid as they identify different aspects of an anxiety presentation. These authors 
recommended that for future research, combining ratings from both sources may 
equate to a more valid anxiety variable. Addressing this issue in the design of future 
studies will be important in furthering our understanding of the presentation of 
anxiety in ASD. 
Fifteen studies used child and adolescent samples in their studies. This could mean 
that predictors linked with later developmental stages may be missed. Research 
indicates that anxiety in ASD increases with age (Davis III et al., 2011; Vasa et al., 
2013) and so it could be that different life and environmental factors associated with 
adulthood are playing a role in increased anxiety in adults with ASD. By focusing 
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mainly on child participants, these relationships may be missed. Additionally, only 
one study (Neuhaus et al., 2016) used a longitudinal design to investigate predictors 
of anxiety. This highlights the dearth of research examining causal mechanisms of 
anxiety in autism using longitudinal designs, which are more methodologically 
robust than cross-sectional designs when attempting to draw causal links. 
Finally, the measures used to assess anxiety in the studies were diverse and not 
validated in ASD populations. Rodgers et al. (2016) highlights the difficulties with 
this approach as the presentation of anxiety in ASD seems to be associated with a 
range of ASD phenomenology such as sensory processing difficulties, repetitive 
behaviour and social impairments. It can be difficult to differentiate the features of 
ASD and anxiety. In this review, Kerns et al. (2014) outlined the differences in 
‘traditional’ anxiety and ‘atypical’ anxiety in ASD. Whilst traditional anxiety may be 
adequately assessed using measures from the normative population, it is possible that 
the ‘atypical’ anxiety symptoms may not. Wigham and McConachie (2014) 
systematically reviewed anxiety measures used to assess outcomes in CBT trials for 
children with ASD. They examined 63 full-text articles and assessed the quality of 
their anxiety measures using the COSIM checklist (Consensus Based Standards for 
the selection of Health Based Measurement Instruments) (Mokkink et al., 2010). 
Measures were assessed for internal consistency, reliability, content validity, 
hypothesis testing, criterion validity and construct validity. They found three 
measures to be suitable for children with ASD. These were the SCAS (Spence, 
1998), the Revised Children’s Anxiety and Depression Scale (Chorpita, Moffitt, & 
Gray, 2005) and the SCARED (Monga et al., 2000).  Only four studies in this review 
used one of these measures (Boulter et al., 2014; Hollocks et al., 2016; Kerns et al., 
2014; Palser et al., 2018). In addition to these three measures- 14 different measures 
of anxiety were used across the 19 studies reviewed. This finding highlights the 
variability and inconsistency in the measurement of anxiety in ASD research, and 
demonstrates the need for validated, consistent measures to be used in order to draw 
meaningful and comparable conclusions from the data.  
1.4. Discussion 
This review aimed to summarise and critique quantitative research investigating the 
predictors of anxiety in ASD. The results of this review brought together several 
disparate findings and attempted to organise them in a meaningful way.  
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Nineteen papers were reviewed and the results were synthesised into eight key 
predictor concepts; social skills and behaviour, sensory sensitivities, cognitive and 
executive related skills, emotional regulation and awareness, physiological arousal, 
language ability, face processing and demographic variables. The predictors 
identified from this review are summarised in Figure 1.2.  
The results of this review highlight the complexity of the mechanisms underpinning 
anxiety in ASD. Most of the studies reviewed found several different predictor 
variables, while those conducting mediation analyses found interactions between 
variables which contributed to the presence of anxiety in ASD. What remains 
unclear is the precise nature of the relationships between the identified predictors, 
ASD symptomatology and anxiety. It is possible that the presence of deficits in 
social skills, ToM, executive function and sensory sensitivities result in the 
presentation of ASD (social communication and interaction difficulties and repetitive 
behaviour) which then predicts anxiety. Alternatively, it is possible that the ASD 
presentation make the presence of certain predictors more likely which results in 
anxiety. Or, perhaps it is a combination of both potential pathways which results in 
elevated anxiety levels in ASD. Some variables, for example, intolerance of 
uncertainty, have been found to mediate the relationship between ASD 
symptomatology and anxiety in ASD (Boulter et al., 2014). This suggests that 
different predictors could be influencing the pathway between ASD symptomatology 
and anxiety at different points. 
In Kerns and Kendall (2012) review, they discussed the difficulties with separating 
anxiety and ASD symptoms and questioned whether anxiety in ASD should be 
considered a core symptom of ASD or whether it is a separate and distinguishable 
co-morbidity. The authors reviewed relevant literature and concluded that, whilst the 
research shows high variability in methodology, results suggest that it is likely that 
anxiety is a co-occurring disorder rather than a characteristic feature of ASD.  The 
authors concluded that several research studies indicate that ASD may be a 
predisposing factor for anxiety disorders. When examining theories of causation- 
Kerns and Kendall (2012) outlined sensory over-responsivity and social deficits as 
being indicated in the research as factors causing anxiety in ASD. This review 
supports those assertions, with findings from several of the reviewed studies 
implicating sensory features (Bitsika et al., 2019; Kerns et al., 2014; Palser et al., 
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2018) and social deficits (Bellini, 2006; Bitsika & Sharpley, 2018; Dubin et al., 
2015; Lei & Ventola, 2018; Niditch et al., 2012; Swain et al., 2015) as having a role 
in anxiety in ASD.  
Evaluating theories of indirect causation, Kern and Kendall (2012) cited emotional 
regulation difficulties and reduced cognitive abilities as examples where ASD 
deficits are indirectly contributing to anxiety symptoms. The findings of this review 
supports these predictors (Cai et al., 2018; Maisel et al., 2016; Swain et al., 2015; 
Uljarević et al., 2017) as playing a role in anxiety in ASD. Finally, Kerns and 
Kendall (2012) suggested that there are several hypothesised pathways in which 
ASD deficits cause anxiety symptoms and that these require further investigation. 
Again, this review supports those assertions  
This review highlighted the dearth of literature investigating the predictors of anxiety 
in ASD. Of the 3931 studies originally selected, only 19 met the inclusion criteria 
which mainly consisted of a confirmed ASD diagnosis and statistical analyses which 
allowed causal links to be made between variables and anxiety in ASD. As outlined 
in Figure 1.2, the mechanisms behind anxiety in ASD are complex and further 
research is needed to understand better these relationships in order to develop 
effective intervention strategies. Additionally, whilst Figure 1.2 provides an 
overview of the predictors identified in current literature, some mediating variables 
of anxiety may not have been identified thus far. It is anticipated that additional 
variables may be implicated in anxiety in ASD in future research.  
.  
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1.4.1 Limitations 
This review focused on quantitative research which used statistical analysis allowing 
causal links to be made between variables and anxiety in ASD. The results presented 
must be considered in the context of certain limitations.  There was high variability 
in the measures of anxiety utilised across the nineteen studies. None of the studies 
used measures of anxiety that have been validated specifically in the ASD 
population, although four studies (Boulter et al., 2014; Hollocks et al., 2016; Kerns 
et al., 2014; Palser et al., 2018) used measures that have latterly been found to be 
robust and suitable for ASD populations (Wigham & McConachie, 2014). Whilst the 
other anxiety measures used in the studies in this review may be able to identify 
‘typical’ anxiety symptomatology, more specific ASD-related anxiety symptoms 
may not have been identified. This review highlights the importance of using 
appropriate and validated measures in ASD populations and emphasises the need for 
future studies to use these validated measures.  
 Agreement between parent and child rated measures was also variable and 
highlighted the difficulty in using parent-report measures of emotional difficulties in 
ASD. Whilst this is a common methodological difficulty in looking at anxiety in 
ASD, and is representative of the current literature about anxiety in ASD, it does 
mean that conclusions drawn about predictors of anxiety in ASD should be made 
with caution.  
Additionally, several papers were excluded from this review because they only 
carried out correlation analysis, therefore meaning that causal links could not be 
made between predictors and anxiety. Some factors such as the functioning of the 
amygdala (Herrington et al., 2017; Herrington, Miller, Pandey, & Schultz, 2016) 
were reported in several studies and may indeed represent additional predictors of 
anxiety in ASD. However, due to the aims of this review it was considered important 
to only include papers demonstrating a direct predictive relationship between 
variables and anxiety. This could mean that some predictors are absent from this 
review. Furthermore, only one longitudinal study was identified as meeting the 
inclusion criteria for this review. The remaining studies were cross-sectional in 
design. Whilst regression analyses can point to predictive relationships between 
variables, the gold standard research design for inferring causality is randomised 
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control trials (longitudinal design) whereby data are collected at several time points 
(Wunsch, Russo, & Mouchart, 2010). That only one longitudinal study was 
identified highlights the need for further longitudinal studies to be conducted to 
elucidate the relationship between predictive variables (as identified in current cross-
sectional studies) and anxiety in ASD.   
Finally, the majority of the papers in this review examined predictors of anxiety in 
children with ASD as opposed to adults. Whilst arguably this is important as 
knowing the predictors in childhood could lead to early intervention for anxiety, and 
better outcomes as a consequence into adulthood, it does mean that certain predictors 
which may influence anxiety further along in development may not be identified by 
excluding adult participants.  
1.4.2 Clinical implications 
The high prevalence of anxiety in ASD means that interventions for anxiety in ASD 
have been more recently studied. Most interventions follow a cognitive behavioural 
therapy (CBT) structure and have demonstrated good results for people with ASD. 
Kester and Lucyshyn (2018) conducted a systematic review of modified CBT 
interventions for anxiety in ASD. Across 30 studies they concluded that CBT could 
be considered as an empirically supported treatment for children with ASD and 
anxiety.  
With the identification of predictors of anxiety in ASD comes the potential for 
development of new, targeted interventions for anxiety. Rodgers et al. (2017) 
developed an intervention aiming to increase tolerance of uncertainty in children 
with ASD, following their research identifying intolerance of uncertainty as a 
predictor of anxiety. The intervention, whilst only reported as a pilot study, focused 
on increasing a child’s tolerance of uncertain events. Rodgers et al. (2017) reported 
promising results in parent-reported outcomes. Rodgers, Herrema, Honey, and 
Freeston (2018) later trialled a similar intervention working directly with adults with 
autism to teach them strategies to manage uncertainty. This pilot study also showed 
promising results in the feasibility and applicability of the intervention. Further work 
is now needed to firm up these interventions and provide additional evidence of its 
clinical applicability. Separately, Thomson, Riosa, and Weiss (2015) delivered an 
intervention aimed at improving emotional regulation in children with ASD. The 
     45 
intervention consisted of activities such as computer games, modelling and role play 
to practice emotional regulation skills, psycho-education about emotions and 
relaxation and mindfulness sessions. Outcome measures following intervention 
suggested both parent and child reported improvements in mood and an overall 
decrease in emotional dysfunction and an increase in emotional regulation strategies. 
Whilst these are single studies, they show promising results for targeting specific 
predictors of anxiety in ASD in order to improve anxiety and overall wellbeing. 
1.4.3 Future Directions 
This review has identified gaps in the literature regarding assessment of anxiety in 
ASD. None of the studies in this review used ASD-specific measures of anxiety. 
Given the risk of possible diagnostic overshadowing, it is important that future 
research uses population-specific assessments of anxiety such as the Anxiety Scale 
for Children with ASD (Rodgers et al., 2016). Furthermore, there is a need for more 
longitudinal studies to examine the relationship between identified predictive 
variables and anxiety in ASD, to be able to definitively make causal inferences about 
the relationships between predictors and anxiety. Understanding and summarising 
the predictors of anxiety in ASD will be useful for the development of specific 
anxiety interventions in the population. Research examining such protective factors 
would be useful to complement the knowledge base regarding predictors of anxiety, 
and intervention strategies could target both predictive and protective factors.  
1.4.4 Conclusion  
Research indicates a high prevalence of anxiety in ASD, a wide variety of anxiety 
presentations and multiple risk factors associated with the development and 
maintenance of anxiety in ASD. The current review set out to critically evaluate 
quantitative research examining the variables predicting anxiety symptoms in people 
with ASD. Findings from the studies reviewed here point to a complex interaction of 
variables influencing the presentation of anxiety. These variables could be targeted 
to decrease anxiety in people with ASD. Further research is needed to trial 
interventions targeting the identified predictors in order to improve quality of life 
and reduce anxiety symptoms in people with ASD.  
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Aim: Both Cornelia de Lange syndrome and Fragile X syndrome are associated with 
co-morbid autism spectrum disorder and high levels of anxiety. Research in autism 
has found intolerance of uncertainty mediates the relationship between autism 
symptomatology and anxiety. The same relationships may therefore exist in these 
rare genetic syndromes and may inform anxiety interventions for these syndrome 
groups. Method: 68 participants with Cornelia de Lange or Fragile X syndrome took 
part in a cross-sectional questionnaire-based study to examine the relationship 
between intolerance of uncertainty, anxiety and autism symptomatology. Findings: 
Intolerance of uncertainty mediated the relationship between autism and anxiety in 
Cornelia de Lange syndrome participants but not in the Fragile X syndrome sample. 
Conclusion: Results are discussed in relation to the current autism literature. It is 
suggested that other factors may be contributing to the autism-anxiety relationship in 
Fragile X syndrome. Recommendations are made for future intervention-based 
research for the management of anxiety in Cornelia de Lange syndrome. 
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Rare genetic syndromes associated with intellectual disability have a prevalence of 
approximately 1 in 213 to 1 in 448 live births (dependent on parent age; Study et al., 
2017) in the general population. These syndromes are often associated with 
increased risk of mental health difficulties such as anxiety (Basile, Villa, Selicorni, 
& Molteni, 2007; Cordeiro, Ballinger, Hagerman, & Hessl, 2011; Dykens, Hodapp, 
& Finucane, 2000). Many rare genetic syndromes are also associated with an 
increased prevalence of autism spectrum disorder (ASD). Richards, Jones, Groves, 
Moss and Oliver (2015) systematically reviewed the prevalence of ASD in rare 
genetic syndromes and reported on sixteen syndromes associated with ASD across 
available literature. These included Fragile X, Cornelia de Lange, Williams’, Rett 
and Down syndrome. Across all the syndromes identified, ASD phenomenology was 
significantly more likely compared to the general population. Given that ASD is also 
associated with an increased prevalence of anxiety disorders (Strang et al., 2012), 
research investigating the link between ASD symptomatology and anxiety in rare 
genetic syndromes could further our understanding of the anxiety-ASD relationship 
and highlight potential new interventions for anxiety in rare genetic syndromes 
associated with both ASD and anxiety.   
2.1.1 ASD 
ASD is a neurodevelopmental disorder with a prevalence of approximately 1% in the 
typically developing (TD) population (Simonoff et al., 2008), and approximately 
40% in people with a severe to profound intellectual disability. ASD is characterised 
by difficulties in social-communication and by repetitive behaviours and restricted 
interests. Until recently, a diagnosis of ASD required impairments in a ‘triad’ of 
domains, namely social communication, reciprocal social interaction and repetitive 
behaviours/restrictive interests (Wing, Gould, & Gillberg, 2011). The DSM-5 
(American Psychiatric Association, 2013). amended these criteria to a ‘dyad’ of 
impairments, with difficulties in reciprocal social interaction now falling under the 
‘social communication’ category of difficulties.  
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2.1.1.1 Anxiety in ASD 
 In people with ASD, estimated prevalence rates of anxiety are in excess of 40% 
(Leyfer et al., 2006). Alongside high prevalence rates for anxiety in people with 
ASD, research indicates that at least 50% of people with ASD will experience 
anxiety that has a significant impact on their day to day lives. Anxiety in people with 
ASD can present differently from anxiety in TD people (Kerns et al., 2014; Rodgers 
& Ofield, 2018). This can make assessing anxiety in people with ASD problematic, 
as most measures of anxiety are designed for the TD population. Research indicates 
that when someone with ASD is anxious they may spend more time on their specific 
interests, their behaviour may become more repetitive and they may become more 
rigid and insistent on their routines (Joyce, Honey, Leekam, Barrett, & Rodgers, 
2017; Rodgers & Ofield, 2018). 
Other behaviours associated with anxiety in ASD include: self-injury, increased 
repetitive and ritualistic behaviours, and avoidance (Leyfer et al., 2006; Wigham, 
Rodgers, South, McConachie, & Freeston, 2015). As well as anxiety being 
distressing to experience, it could have additional consequences such as someone 
with a neurodevelopmental disorder missing out on life experiences, as well as 
impacting on educational and developmental goals. As anxiety can have such wide-
reaching consequences for an individual experiencing it, being able to both describe 
and explain the presence of anxiety is important.  
2.1.2 Intolerance of uncertainty 
A better understanding of the nature of anxiety in neurodevelopmental disorders, and 
its causes can point to appropriate interventions to decrease anxiety in these 
disorders. In ASD, recent studies have started to answer these questions and 
indicated a role for ‘intolerance of uncertainty’ (IU) in the presence of anxiety in 
both typical development and in ASD (Rodgers, Glod, Connolly, & McConachie, 
2012).  IU is the term used to describe a ‘desire for predictability’ (Birrell, Meares, 
Wilkinson, & Freeston, 2011, p. 1205) and paralysis of cognition and action in the 
face of uncertainty (Birrell et al., 2011). People with IU both avoid uncertain 
situations, and have difficulty functioning in them (Boelen & Reijntjes, 2009). IU 
was initially implicated in the development and maintenance of generalised anxiety 
disorder and worry (Freeston, Rhéaume, Letarte, Dugas, & Ladouceur, 1994) and 
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has now been identified as a critical factor underpinning a wide range of anxiety 
disorders (Norr et al., 2013) including social anxiety disorder, panic disorder and 
separation anxiety and anxiety-related conditions such as obsessive compulsive 
disorder (OCD).  
Whilst research has mainly focussed on TD adults and children, evidence is 
emerging for the presence of IU in individuals with ASD. For example, Boulter, 
Freeston, South, and Rodgers (2014) compared IU and anxiety in typically 
developing children and children with ASD and modelled the relationships between 
ASD symptomatology, IU and anxiety. They found that (both with parental and child 
reports) levels of anxiety and IU were significantly higher in the ASD group. 
Furthermore, when the effect of IU was controlled for, there was no longer a 
significant difference between the groups. Results were consistent with a causal 
model of IU mediating the relationship between ASD and anxiety. This indicates that 
IU may play a causal role in the development of anxiety in ASD.  
Elsewhere, Wigham et al. (2015) examined the relationships between sensory 
processing abnormalities, anxiety, repetitive behaviour and IU in children with ASD 
using questionnaire measures. It was found that sensory under responsiveness 
(seeking sensation) was linked to repetitive behaviours and sensory over 
responsiveness (sensory avoiding and sensitive to stimuli) was linked to insistence 
on sameness. Importantly, IU was found to be a mediating factor between sensory 
processing abnormalities and anxiety. IU and anxiety also mediated the relationship 
between sensory processing abnormalities and the presence of restricted/repetitive 
behaviours.  
In their study, Hodgson, Freeston, Honey, and Rodgers (2017) explored the concept 
of IU in people with ASD using parent focus groups as a preliminary step towards 
developing an intervention for IU in people with ASD. Parents were asked to share 
experiences of their child’s anxiety and IU. Parents were able to reach a consensus 
about how IU is defined and how it presents in children with ASD. Parental 
examples of IU included whether an event was unexpected and if an event was 
expected but parts of the event were unknown. They also included events which 
were familiar such as being at home and novel situations such as going somewhere 
new on holiday.  
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As well as IU predicting anxiety in people with ASD, studies have demonstrated that 
IU is also related to other ASD specific features. Neil, Olsson, and Pellicano (2016) 
found using questionnaire measures that, as well as IU mediating the relationship 
between ASD symptomatology and anxiety, IU also mediates the relationship 
between ASD symptomatology and sensory sensitivities even when the effects of 
anxiety were controlled for. The authors suggested that IU may result in attempts to 
reduce uncertainty in the environment. This may increase anxiety symptoms such as 
rumination and increased hyper vigilance to threatening environmental stimuli. This 
may lead to heightened sensory sensitivity.   
In their cross-sectional questionnaire study, Vasa, Kreiser, Keefer, Singh, and 
Mostofsky (2018) found significant relationships between both severity of social 
communication difficulties and severity of repetitive behaviour with IU. 
Furthermore, they found that emotional dysregulation was predictive of IU when 
controlling for anxiety. They concluded that as well as anxiety, IU has unique 
relationships with many features of ASD which may explain the high levels of IU 
seen in ASD. They also suggested that the relationship between ASD features and IU 
may be a result of overlapping neurobiological networks, and therefore possibly 
heritable.  
2.1.2.1 IU in rare genetic syndromes 
Given the recent findings on IU in ASD, and the implications for understanding 
anxiety in this population and developing effective interventions, it would be 
valuable to establish if similar relationships between IU and anxiety exist in other 
neurodevelopmental disorders.  
Uljarević, Labuschagne, Bobin, Atkinson, and Hocking (2018) investigated 
associations between anxiety and both IU and sensory sensitivities in people with 
Williams Syndrome (WS) and found that IU and sensory hypersensitivity were 
unique predictors of anxiety in the syndrome. ASD symptomatology measured by 
the Social Responsiveness Scale (SRS) was not found to predict anxiety in WS. This 
pattern resembles that observed in current ASD literature ((Boulter et al., 2014; 
Wigham et al., 2015). The authors emphasised the need for interventions to address 
IU and beliefs about unpredictable situations for people with WS.   
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Uljarević et al. (2018) provided a first examination of the IU-anxiety relationship in 
a rare genetic syndrome associated with ASD. As different syndromes have different 
associated behavioural phenotypes and presentations of anxiety, it would be 
appropriate to investigate whether this relationship applies to other syndromes 
associated with anxiety and ASD symptomatology.  
2.1.3 Cornelia de Lange syndrome 
Cornelia de Lange syndrome (CdLS) is a rare genetic syndrome with an estimated 
prevalence of between 1 in 10,000 (Opitz & Reynolds, 1985) to 1 in 100,000 live 
births (Barisic et al., 2008). It is caused by varying mutations in the NIPBL (Krantz 
et al., 2004), SMCA, HDAC8, RAD21(Deardorff et al., 2012; Deardorff, Noon, & 
Krantz, 2016),  and SMC3 (Revenkova et al., 2008) genes which disrupt gene 
regulation during early critical development. Mutations in the NIPBL genes have 
been identified in over 50% of people with CdLS (Krantz et al., 2004). Mutations in 
the other genes are less common. CdLS presents with a number of distinctive 
physical characteristics (Kline et al., 2007). These include a proportionate short 
stature, small hands and feet, abnormal limb development and upper extremity limb 
malformations (in approximately 30% of cases). Facial features include synophrys, a 
small nose with depressed bridge, a thin downturned lip and an elongated philtrum 
(Kline et al., 2007). There are also some associated health problems which include 
congenital heart problems, renal malformations, dental problems, hip abnormalities 
and a high prevalence of gastro-oesophageal reflux disease (GORD), which often 
requires surgical intervention. Intellectual disability (ID) in CdLS can range from 
mild to profound (Berney, Ireland, & Burn, 1999).  
2.1.3.1 Behavioural phenotype overview 
CdLS has an associated behavioural phenotype of repetitive behaviours, self-
injurious behaviour, an expressive-receptive language discrepancy, ASD 
phenomenology and high levels of social anxiety (Berney et al., 1999; Oliver, Arron, 
Sloneem, & Hall, 2008). Research into social anxiety in CdLS point to social 
impairments consistent with a social anxiety presentation. Arron et al. (2006) 
showed people with CdLS demonstrating socially avoidant behaviour, while 
Richards, Moss, O’Farrell, Kaur, and Oliver (2009) found that people with CdLS 
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were significantly more likely to show behaviours indicative of social anxiety 
compared to another rare genetic syndrome. 
2.1.3.2 ASD in CdLS 
A strong association with ASD-symptomatology in CDLS has been demonstrated in 
several studies, although early studies found these were associated with moderate to 
profound intellectual disability only (Basile et al., 2007; Berney et al., 1999). 
However, Oliver et al. (2008) compared ASD symptomatology in CdLS to a 
matched ID group and found that the CdLS group were more likely to be classed as 
‘severely’ autistic even when controlling for level of ID. The authors suggested that 
autism in CdLS cannot be explained by ID alone. Using the Autism Diagnostic 
Observation Schedule (ADOS; Lord et al., 2000),  Moss, Howlin, Magiati, and 
Oliver (2012) found that people with CdLS showed less repetitive behaviour and 
stereotyped speech and more eye contact compared to people with ASD, resulting in 
different profiles of subscale scores on the ADOS assessment. However, the subscale 
scores on the ADOS still reached clinical cut-off for a diagnosis of ASD. 
2.1.3.3 Anxiety in CdLS 
Research has recently started to investigate the nature of anxiety in CdLS and 
findings indicate anxiety prevalence rates of between 10 and 64%. Arron et al. 
(2006) used analogue methodology (experimentally manipulating environmental 
variables to assess the effects of those variables on behaviour) to evaluate the impact 
of levels of attention on social behaviour in CdLS. They found that 77% of 
participants with CdLS demonstrated socially avoidant behaviour such not 
complying with a request or  moving away from physical contact and during 
interactions. Richards et al. (2009) used functional analysis to compare behaviours 
indicative of anxiety in 12 participants with CdLS and 12 participants with Cri du 
Chat syndrome (CdCS) in different social situations. They found participants with 
CdLS to be significantly more likely to display behaviours indicating social anxiety 
during high social demand than the CdCS group.  
Crawford, Waite, and Oliver (2017) investigated and compared anxiety profiles and 
symptomatology across three rare genetic syndromes, namely CdLS, Fragile X 
syndrome (FXS) and Rubinstein-Taybi syndrome (RTS) using questionnaire 
measures. The CdLS group showed higher levels of generalised anxiety disorder 
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(GAD) and separation anxiety compared to typically developing children and FXS 
and RTS syndrome comparison groups. When compared to TD children with 
diagnoses of GAD or separation anxiety, no significant differences were found 
between them and the CdLS group. The authors suggested that these results 
highlighted the severity and breadth of anxiety disorders in people with CdLS.  
2.1.3.4  CdLS and IU 
Anecdotal reports from parents of children with CdLS suggest that high levels of 
anxiety can occur when situations are unpredictable or novel, for example, if their 
child is going to a new place or to an event to which they have never previously 
been. Given the presence of ASD phenomenology in CdlS, it is possible that these 
descriptions of anxiety in CdLS could be underpinned by IU, as found in ASD 
(Boulter et al., 2014; Rodgers, Freeston, South, Wigham, & Boulter, 2012).  This 
possibility provides a rationale for investigating a link between anxiety and IU in 
CdLS. If IU is also underpinning anxiety in CdLS as in ASD, clinical interventions 
and approaches could be developed for people with CdLS to manage their anxiety 
and could improve quality of life.  
2.1. 4 Syndrome comparison group: 
Whilst assessing performance of those with a particular syndrome on different 
measures can provide valuable information, comparisons with other syndrome 
groups allows for characteristics/behaviour to be identified as either related to a 
particular syndrome or related to the level of intellectual disability more generally. 
Therefore, this study used a syndrome comparison group in its methodology.  
Fragile X syndrome (FXS) is a rare genetic syndrome which is the most common 
cause of inherited intellectual disability and has a prevalence of approximately 1 in 
2,500-5,000 males (Coffee et al., 2009). FXS is caused by mutations in the Fragile X 
Mental Retardation 1 (FMR1) gene on the X chromosome. As FXS is an X linked 
disorder, far fewer females are affected and often present with phenotypic 
differences compared to males with FXS (Clifford et al., 2007). Due to the 
differences in presentation between males and females, this study only recruited 
males with FXS. It is associated with mild to profound intellectual disability and a 
range of physical and behavioural characteristics. The associated behavioural 
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phenotype includes social anxiety, ASD-symptomatology, hyperactivity, hyper-
arousal to sensory stimuli and high levels of repetitive behaviour (Garber, Visootsak, 
& Warren, 2008).  
The nature of anxiety in FXS has been reported in the literature and parental reports 
indicate the presence of high levels of anxiety in FXS. Ezell et al. (2019) compared 
prevalence of anxiety disorders between FXS and ASD matched participants using a 
diagnostic interview measure of anxiety (Weller, Fristad, Weller, & Rooney, 1999). 
They reported an anxiety disorder prevalence of 51.6% in the FXS group compared 
to 50% in the ASD group. However, in the ASD group the most prevalent disorder 
was GAD whereas in FXS it was specific phobia. This highlights differences in the 
presentation and manifestation of anxiety in FXS compared to ASD samples. 
Cordeiro et al. (2011) used the Anxiety Disorders Interview Schedule (Grisham, 
Brown, & Campbell, 2004) to assess anxiety in 97 males and female participants 
with FXS. They found that approximately 86% of their sample met diagnostic 
criteria for an anxiety disorder, with 65% meeting cut off for Specific Phobia and 
35%, social phobia. Crawford et al. (2017) used questionnaire-based measures to 
investigate anxiety profiles in FXS and other genetic syndromes compared to TD 
populations. Using the Spence Child Anxiety Scale (Spence, 1998), they found that 
the FXS group were comparable with TD populations except for being slightly 
higher on the panic/agoraphobia subscale. The FXS group were also comparable for 
children diagnosed with an anxiety disorder on most subscales. For total anxiety 
scores, people with FXS scored lower that children diagnosed with an anxiety 
disorder.  
Whilst anxiety disorders have been reported and investigated in FXS, mediating 
factors for the presence of anxiety in the syndrome such as IU have not previously 
been investigated. 
2.1.5 Rationale and Aims 
Understanding the nature of anxiety, and the factors underpinning it in CdLS is 
important for developing tailored interventions to reduce anxiety in the syndrome.  
As outlined previously, IU has been implicated in the presence of anxiety in ASD. 
Given the associations between ASD and CdLS, it is possible that the same 
relationship exists in CdLS and other syndromes associated with ASD.  
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In line with the above rationale, this study set out to answer the following research 
questions 
1) How do IU and anxiety compare between CdLS and a syndrome comparison 
group (FXS)? 
2)  How are IU, anxiety and autism symptomatology related in CdLS and FXS? 
3) Does IU mediate the relationships between autism symptomatology and anxiety in 
CdLS and FXS? 
2.2 Method 
2.2.1 Ethical approval 
This study was conducted in accordance with the British Psychological Society’s 
ethical guidelines (BPS, 2009). Ethical approval was granted from the University of 
Birmingham Ethics Committee and from the NHS Ethical Review for these 
measures, data collection methods and populations to be used as part of a larger 
research project. Approval was granted from Coventry University Ethics Committee 
to analyse the data. (See Appendix C) 
2.2.2 Recruitment  
Participants for this study were recruited as part of a larger ongoing cross syndrome 
project.  
A total of 130 parents/carers of children with FXS or CdLS syndromes were 
contacted as part of an ongoing study investigating anxiety presentations in rare 
genetic syndromes. 85 parents/carers chose to take part in the ongoing study. 
Participants were contacted via an existing database at the Cerebra Centre for 
Neurodevelopmental Disorders at the University of Birmingham which was 
compiled through recruitment via the appropriate syndrome support groups; Cornelia 
de Lange Foundation UK and Ireland and the Fragile X Society.  
2.2.3 Participants  




1) Having a confirmed genetic diagnosis of CdLS or Fragile X syndrome. 
2) The presence of a mild to moderate intellectual disability 
3) Aged four years and upwards 
 
Participants without a confirmed diagnosis of the genetic syndrome from the medical 
professional (GP, clinical geneticist or paediatrician) were excluded from analysis. 
Participants were also excluded if less than 75% of the questionnaire had been 
completed. Participants were matched on chronological age and ability using the 
Communication subscale and the Adaptive Behaviour Composite score from the 
Vineland Adaptive Behaviour Scale (VABS) (Sparrow, Cicchetti, Balla, & Doll, 
2005). Questionnaire measures were completed by participants’ parents/carers.  
Details of participant demographics are displayed in Table 2.1, and results of 
statistical analyses detailing significant differences between demographics are 
displayed.  
2.2.4 Procedure 
Information sheets, consent forms and questionnaire packs were sent out to families 
(or distributed at syndrome support group meetings or home visits) who indicated 
interest in participating in research at the Cerebra Centre, and whose details were 
therefore held on the participant database. As this was part of a larger ongoing 
project, some further measures were included in this pack which did not form part of 
the present study. 
2.2.5 Measures 
The following questionnaires were sent to parents/carers:  
2.2.5.1Demographic information 
The demographic questionnaire asks parents to confirm their child’s age, gender, 
verbal ability, mobility status and details of diagnosis 
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2.2.5.2 Measure of ability: 
Vineland Adaptive Behaviour Scale (VABS) second edition (Sparrow et al., 2005) 
The VABS is a parent/carer interview measure that assesses adaptive behaviour in 
four key domains: daily living, communication, socialisation, and motor skills. It is 
used for typically developing children (aged from birth to 18) and is also widely 
used for children and adults with intellectual disabilities. Internal consistency for the 
total score was high when tested in children and adults with intellectual disabilities 
(Cronbach’s Alpha = .99) and the VABS is strongly positively correlated with the 
Social Functioning Scale for the Mentally Retarded (r=.93; de Bildt, Kraijer, 
Sytema, & Minderaa, 2005).  
Cronbach’s alpha for the CdLS group on this measure was excellent (α=.94)  and 
excellent for the FXS group (α=.93) 
This measure was administered in telephone interviews between the researcher and 
parent/carer.  
 
2.2.5.3 Measure of ASD symptomatology: 
Social Responsiveness Scale- Second edition (SRS-2)(Constantino & Gruber, 2012) 
The SRS-2 is a 65-item rating scale that measures the severity of ASD symptoms. 
There are five subscales: Social Awareness, Social Cognition, Social 
Communication, Social Motivation and Restricted Interests and Repetitive 
Behaviour. The SRS-2 offers three different forms, suitable for different ages (2.5-4 
years, 4-18 years and 19 years +), that are completed by parents or teachers in 
approximately 15-20 minutes. This version is identical to its predecessor, the SRS, 
which has been shown to correlate strongly (r = .65-.77) with the Autism Diagnostic 
Interview – Revised (ADI-R; Le Couteur, Lord, & Rutter, 2003). The SRS-2 also has 
good inter-rater reliability (r = .75-.91) and scores are not related to IQ (Constantino 
& Gruber, 2007). In order to ensure a good spread of scores for statistical analyses, 
the total raw scores from the SRS were used in this study rather than t-scores. 
Cronbach’s alpha for the CdLS group on this measure was excellent  (α=.93)  and 
good for the FXS group (α=.87) 
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2.2.5.4 Measures of anxiety 
The Anxiety Scale for Children-ASD (ASC-ASD) (Rodgers et al., 2016) 
The ASC-ASD is a 24 item anxiety rating scale with four subscales: Performance 
Anxiety, Uncertainty, Anxious Arousal, and Separation Anxiety. This measures 
anxiety related items that are particularly appropriate to the specific phenomenology 
of anxiety in ASD. There are two versions of the ASC-ASD, a child self-report and a 
parent report. The parent report version was used in the current study. Internal 
consistency is good to excellent (Cronbach’s alpha for: full scale: .94; performance: 
.89; separation: .87; arousal: .87; anticipatory: .91). One month test-retest reliability 
is excellent (r=.84) and convergent validity has been demonstrated by significant 
strong correlations between the ASC-ASD and the Screen for Child Anxiety Related 
Emotional Disorders (SCARED; Birmaher et al., 1997) 
Cronbach’s alpha for the CdLS group on this measure was excellent (α=.94)  and 
acceptable for the FXS group (α=.75) 
 
The Anxiety, Depression, and Mood Scale (ADAMS) (Esbensen, Rojahn, Aman, & 
Ruedrich, 2003)  
The ADAMS is a 28-item informant report designed to screen for anxiety, 
depression and mood disorders among individuals with intellectual disability. There 
are five subscales: Manic/Hyperactive Behaviour, Depressed Mood, Social 
Avoidance, General Anxiety and Compulsive Behaviour. The ADAMS has 
satisfactorily high alphas for each of the subscales, with a mean Cronbach’s alpha of 
.80 and robust test-retest correlations at the scale and subscale level (mean subscale 
= .78). 
Cronbach’s alpha for the CdLS group on this measure was good (α=.88)  and 
acceptable for the FXS group (α=.71) 
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2.2.5.5 Measure of intolerance of uncertainty: 
Intolerance of Uncertainty Scale – Parent Version (Rodgers, Freeston, et al., 2012) 
The Intolerance of Uncertainty scale is a 12-item informant questionnaire used to 
assess an individual’s ability to cope with uncertainty in particular situations. 
Parents/carers are asked to indicate on a 5-point likert scale how well 12 statements 
describe their child. The measure yields a total score, for which higher scores 
indicate greater levels of intolerance to uncertainty. The scale has been found to have 
excellent internal consistency reliability in both TD individuals and individuals with 
ASD (Boulter et al., 2014) 
Cronbach’s alpha for the CdLS group on this measure was excellent (α=.92)  and 
good for the FXS group (α=.83) 
2.2.6 A comment on measures of anxiety and intolerance of uncertainty 
There are currently no measures of anxiety validated in both CdLS and FXS which 
can be used across children and adult participants. The ASC-ASD anxiety measure 
was validated in children (up to 16 years) with autism but without intellectual 
disability. Due to the ASD-links in both CdLS and FXS, it was considered a suitable 
measure to be used to identify ASD-related anxiety behaviours. The ADAMS 
(Esbensen et al., 2003) was selected as it is currently the only validated measure of 
anxiety and mood in people with intellectual disability. It was validated in adults. 
The GA (general anxiety) subscale was used in this study specifically as the total 
score includes subscales relating to depressive moods. Cordeiro et al. (2011) 
validated the use of the ADAMS in people FXS aged five-33 years using the 
Anxiety Disorder Interview Scale (Grisham et al., 2004). The GA scale was found to 
correlate highly with a number of subscales on the ADIS, suggesting it is a good 
measure of overall anxiety. Therefore, it was considered methodologically sound to 
use the subscale scores from the GA as representative of anxiety symptoms.  
2.2.7 Data analysis 
The distribution of IUS-P, ADAMS General anxiety subscale, ASC-ASD total 
scores and SRS total raw scores across participant groups were examined using 
visual examination of stem and leaf plots and the Shapiro-Wilk test. All scores were 
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found to be normally distributed with the exception of the ASC-ASD total scores in 
the CdLS group. Attempts to transform the data to a normal distribution were 
unsuccessful.  
The data analysis strategy therefore includes both parametric and non parametric 
tests depending on the distribution of variables included in each analysis.  
Power analysis 
A post hoc power analysis was conducted using the software package, G*Power 
(Faul, Erdfelder, Lang & Buchner, 2007). The sample size of 68 and a 3 predictor 
variable equation with a medium effect size (f 2 = .15) were used for this analysis. 
The recommended effect sizes used for this assessment were as follows: small (f 2 = 
.02), medium (f 2 = .15), and large (f 2 = .35) (Cohen, 1977). The alpha level used 
for this analysis was p < .05. The post hoc analyses revealed the statistical power for 
this study was .12 for detecting a small effect, .70 for detecting a medium effect and 
power exceeded .97 for the detection of a large effect size. Thus, there was more 
than adequate power at large effect size level, but less than adequate statistical power 
at the small and medium effect size level. Therefore, results (especially non 
significant) should be interpreted with caution.  
 








Median age in years 13.92 20.63 499 .329 
Range 49.75 40.25   
Gender (% Male) 44.12 100   


















2.3.1 Comparing anxiety and intolerance of uncertainty between groups  
In order to establish whether there were any differences in key variables between the 
groups, the ADAMS-GA, ASC-ASD, IUS-P total scores and SRS raw scores were 
compared between the CdLS and FXS group with a series of t-tests. Results revealed 
no significant differences between CdLS and FXS on any of the measures. Table 2.2 
outlines the results of t-test analyses.  
Table 2.2 ASC-ASD total scores, ADAMS general anxiety subscale scores and IUS-P 
total scores in CdLS and FXS 
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-0.37 61 .71 
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2.3.2 Regression analyses 
In order to determine whether SRS, IUS-P or syndrome group could predict scores 
on the ASC-ASD, a hierarchical multiple regression analysis was carried out. All 
models had a high tolerance (ranging between 0.80-1.00) and low variance inflation 
factor (VIF) (ranging between 1.000-1.30) suggesting a low level of 
multicollinearity between predictors. The Durbin-Watson value was acceptable 
(2.40), suggesting the assumption of independent errors is tenable. 
 In the first step of hierarchical multiple regression, SRS scores were entered. This 
model was statistically significant. F (1,61) = 10.83 p =.002, and explained 14 % of 
variance in anxiety (ASC-ASD scores). After entry of IUS-P at Step 2 the total 
variance explained by the model as a whole was 60%, F (2,60) = 47.34, p < .001. 
The introduction of IUS-P explained additional 46% of variance in ASC-ASD 
scores, after controlling for SRS scores, R2 = .462 FChange (1, 60) =71.71,  p < 
.001). The higher IUS-P scores, the higher the ASC-ASD scores. Syndrome was 
entered at step 3 of the model and did not significantly contribute to the model. 
Table 2.3 shows the hierarchical linear models for ASC-ASD score.  
The same analysis was carried out with ADAMS-GA scores as the dependent 
variable.  
All models had a high tolerance (ranging between 0.80-1.00) and low variance 
inflation factor (VIF) (ranging between 1.000-1.30) suggesting a low level of 
multicollinearity between predictors. The Durbin-Watson value was acceptable 
(2.12), suggesting the assumption of independent errors is tenable. 
 In the first step of hierarchical multiple regression, SRS scores were entered. This 
model was statistically significant, F (1,61) = 15.34; p =<.001, and explained 19% of 
variance in anxiety (ADAMS-GA scores). After entry of IUS-P at Step 2 the total 
variance explained by the model as a whole was 51%, F (2,60) = 33.77; p < .001. 
The introduction of IUS-P explained additional 33% of variance in ADAMS-GA 
scores, after controlling for SRS scores, R2Change= .329 FChange (1, 60) =41.91  p 
< .001. The higher IUS-P scores, the higher the ADAMS-GA scores. Syndrome was 
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entered at step 3 of the model and did not significantly contribute to the model. 
Table 2.3 Shows the hierarchical linear models for ADAMS-GA score.  
Table 2.3 The Hierarchical Linear Models for ASC-ASD and ADAMS-GA measures 
 B SE B p R R2 AdjR2 
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2.3.3 Mediation analyses strategy 
The regression analyses showed IU strongly predicting anxiety in both CdLS and 
FXS, over and above ASD symptomatology (SRS scores). Therefore, the next step in 
the analyses was to understand the role of IU more specifically using mediational 
analyses. In order to examine the relationship between IU and anxiety in more detail, 
it was considered prudent to separate the syndrome groups and look at the syndrome 
specific relationships between ASD, IU and anxiety. 
2.3.4 Mediation analyses  
In order to establish whether IU is mediating the relationship between autism 
symptomatology and anxiety in CdLS and FXS mediation analysis was conducted 
using the computational tool for mediation and moderation, an SPSS macro called 
PROCESS developed by Preacher and Hayes (2004). The method using a 
bootstrapping procedure to obtain estimates and confidence intervals around the 
indirect effects. Significant relationships in the models are indicated by bootstrapped 
confidence intervals that do not overlap with zero.  In the CdLS group, the total 
effect of SRS scores on anxiety was significant for both measures (ASC-ASD 
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(b=0.18, t= 2.30, p=<.05), ADAMS-GA (b=0.10 , t=3.39 , p=.0019). Table 2.4 
shows the direct and indirect effects of SRS scores on anxiety scores with the 
mediator variable (IU) taken into account. After adjusting for the indirect effect of 
IU, the direct effect did not remain significant for either anxiety measure. Examining 
the 95% confidence interval confirms that ASD symptomatology has a significant 
indirect effect on anxiety through the mediating variable of IU, ASC-ASD b=0.23 
(95% Bootstrapped CI 0.08, 0.39) and ADAMS, b=0.07(95% Bootstrapped CI 0.03, 
0.12). These results indicate that IU is fully mediating the relationship between ASD 
symptomatology and anxiety in the CdLS group.  
In the FXS group, the total effect of SRS scores on anxiety was significant for both 
measures , ASC-ASD b=0. 22, t= 2.65, p=.0129), ADAMS-GA (b=0. 09, t= 2.12, 
p=.0430). Table 2.4 shows the direct and indirect effects of SRS on anxiety with the 
mediator variable (IU) taken into account. After adjusting for the indirect effect of 
IU, the direct effect remained significant for the ASC-ASD measure but not for the 
ADAMS-GA measure of anxiety. Examining the 95% confidence intervals indicates 
that IU is NOT mediating the relationship between ASD symptomatology and 
anxiety scores using either measure. 
Results of the mediation analyses for both CdLS and FXS were consistent using 









Table 2.4: The direct and indirect effects of ASD symptoms on anxiety in CdLS and 
FXS.  
  Direct effect: ASD symptoms 
on anxiety 
Indirect effect: ASD 
symptoms on anxiety 
  ASC-ASD 
  B SE 95% CI B SE 95% 
CI 
CdLS IU -0.04 0.06 -0.16 to 
0.08 
0.22** 0.08 0.08 to 
0.38 
FXS IU 0.15* 0.06 0.02 to 0.28 0.07 0.04 -0.02 to 
0.16 
 ADAMS-GA 
CdLS IU 0.03 0.03 -0.02 to 
0.08 
0.06** 0.02 0.03 to 
0.12 
FXS IU 0.06 0.03 -0.01 to 
0.12 







2.4 Discussion  
This study is the first to investigate the relationships between anxiety, IU and ASD 
symptomatology in CdLS and FXS. This study used groups that were matched for 
age and ability, with good sample sizes for rare populations research.   
First, the total scores on measures of IU, anxiety and autism symptomatology were 
compared between CdLS and FXS groups using a series of t-tests and Mann 
Whitney U tests (for non-parametric data). Results showed no significant differences 
between the CdLS and FXS group on any of the measures (Intolerance of 
Uncertainty Scale, Anxiety Scale for Children with ASD, ADAMS General Anxiety 
Scale or the Social Responsiveness Scale).  
In order to answer the next research question, hierarchical linear regression analyses 
were carried out to determine whether SRS (ASD symptomatology) or IUS-P scores 
(IU) or syndrome group predict anxiety in CdLS and FXS.  For the ASC-ASD 
anxiety measure, SRS scores significantly accounted for the variance in anxiety 
scores at step one, but were no longer significant when IU was added in step two. IU 
scores predicted a significant and large part of the variance and this effect was 
maintained at step three. Syndrome group did not significantly predict any of the 
variance in anxiety scores. Results were consistent for both anxiety measures.  
The results of the regression analyses indicated a significant predictive relationship 
between IU scores and anxiety in both CdLS and FXS, with no significant difference 
in the relationship between the groups. Results also suggest that the relationship 
between autism symptomatology and anxiety scores is no longer significant when IU 
is added into the model.  
The final research question concerned whether IU is mediating the relationship 
between autism and anxiety in CdLS and FXS.  As the regression analyses clearly 
indicated a predictive role of IU to anxiety, it was important to examine and compare 
this relationship in more detail according to syndrome group.  Using Process 
Analysis (Preacher & Hayes, 2004) revealed that IU fully mediated the relationship 
between autism symptomatology and anxiety in CdLS. However, in FXS, the 
method indicated it was unlikely a mediational relationship existed. 
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The results from this study indicate that the relationship between autism 
symptomatology, IU and anxiety in CdLS is comparable to the relationship found in 
people with ASD. IU is a construct that explains the relationship between autism and 
anxiety, and therefore it is possible that targeting IU as an intervention for anxiety in 
CdLS may be beneficial. In FXS, however, the relationship between autism 
symptomatology, IU and anxiety is less clear. Whilst regression analyses indicate 
that IU scores can predict anxiety in FXS, mediation analyses suggested that IU is 
not mediating the relationship between autism symptoms and anxiety. This is 
somewhat surprising given that (like CdLS), FXS is a syndrome strongly associated 
with comorbid ASD, and high levels of anxiety are seen in the syndrome.  
It was considered that the differences in gender could be influencing the results, as 
FXS is an X-linked disorder, participants were all male. Research in autism indicates 
no influence in gender on the predictors of anxiety (Hurtig et al., 2009; Sukhodolsky 
et al., 2008). However, this pattern could be different in these genetic groups and 
future research examining gender differences would be useful. Another possibility is 
that the profile of anxiety differed between CdLS and FXS. Although no significant 
difference was found in the total scores for the ASC-ASD between the groups, it is 
possible that differences in the profiles of the subscale scores may have impacted the 
relationship between IU and the ASC-ASD total scores between the groups. 
However, the same patterns of relationships between IU and anxiety between groups 
were identified when the ADAMS-GA subscale was used as an anxiety measure. 
This indicates that another factor may be influencing the difference in results 
between CdLS and FXS. 
Since the research by Boulter et al. (2014) further studies have also indicated a role 
for sensory sensitivity as a mediating factor between ASD and anxiety. Whilst the 
present study only examined IU, it is possible that in FXS, another factor is 
mediating this relationship. For example, Uljarević et al. (2018) investigated the 
same relationships in people with Williams syndrome (WS). Whilst they found that 
IU predicted anxiety in WS, it was sensory sensitivity that was mediating this 
relationship. Hypersensitivity to sensory stimuli is a characteristic of FXS. In their 
study investigating anxiety profiles in FXS and other genetic syndromes, Crawford 
et al. (2017) suggest that sensory hypersensitivity may contribute to anxiety in 
environments where sensory stimuli is elevated. This may then contribute to the 
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presence of anxiety disorders such as agoraphobia seen in the syndrome, as sensory 
sensitivity leads to avoidance of highly stimulating environments. Therefore, it is 
possible that a factor such as sensory sensitivity may be implicated in relationship 
between ASD symptomatology, IU and anxiety in FXS syndrome. More research is 
needed to further delineate this relationship.   
2.4.1 Limitations 
This study had a number of limitations. First, the measures chosen were parent-
report measures. Boulter et al. (2014) used both parent report and child (participant) 
report measures for the anxiety and IU measures in children with autism but no 
intellectual disability. They found strong correlations between parent and child 
scores, indicating good agreement. However, given the sample population of this 
study, it was unlikely that the participants would have been able to successfully 
complete the measures and reflect on their own experiences of anxiety in order to do 
so due to their level of intellectual disability (Cordeiro et al., 2011). In addition, 
participants included in the study were both children and adults who arguably could 
have different presentations of anxiety due to their developmental differences 
(Spence, 1998). However, Mian, Godoy, Briggs-Gowan, and Carter (2012) 
demonstrated that typically developing children as young as two years old show 
similar clusters of anxiety symptoms to adolescents which correspond to DSM-5 
anxiety disorder diagnostic criteria indicating that anxiety presentations and 
differentiation remain relatively stable overtime. Furthermore, as participants in this 
study had associated intellectual disability, it is more likely that clinically they 
presented similarly in accordance with their developmental rather than chronological 
age.  
A further limitation is that the ASC-ASD has not been validated in people with an 
intellectual disability, but has been validated in children (up to 16 years) with autism, 
while the ADAMS was validated in people with intellectual disabilities but not 
specifically for people with ASD symptomatology.  In fact, there is no equivalent 
measure of anxiety for both children and adults with intellectual disability and ASD. 
The ADAMS (Esbensen et al., 2003) has been validated in participants aged five to 
33 years with FXS syndrome and was therefore considered a good measure to use 
alongside the ASC-ASD, which was used to identify anxiety traits associated with 
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autism in CdLS and FXS. Whilst these measures are not ideal, research into rare 
genetic syndromes comes with such compromises with regard to measures, as it is 
unusual to find a measure that has been specifically validated in a certain syndrome.  
However, using both measures and demonstrating the same relationships with both 
measures of anxiety is encouraging in this regard. Ideally, the study would have 
utilised direct measures of anxiety such as behavioural observations, or physiological 
measures such as heart rate or skin conductance response (SCR). However, due to 
time restraints involved in recruiting such rare populations, this was not possible 
within the parameters of the study.  
A final limitation of this study is that the measure of ability used to match 
participants was a parent-report measure (VABS). Whilst a direct measure of 
receptive language ability was available for some of the participants due to this study 
being part of a concurrent larger study, data were not available for all the 
participants. In order to match participant groups using the direct measure, the 
numbers of participants in each group would have been significantly reduced. It was 
a pragmatic decision to prioritise participant numbers over direct assessment 
matching. Additionally, people with CdLS and FXS syndrome have been found to 
have uneven profiles of skills on cognitive assessments (Johnson, 2015) which may 
be problematic if matching on receptive language level as participants could be 
significantly different on other cognitive skills depending on their syndrome. 
Participants were matched on the communication subscale (receptive, expressive and 
written communication) of the VABS as well as the adaptive behaviour composite 
score. Adaptive behaviour encompasses goal-directed behaviours associated with 
executive function which enable day-to-day functioning. It was considered 
reasonable to match participants on these adaptive behaviours as well as 
communication level using the VABS in order to match participants as well as 
possible without using direct assessment. 
 
2.4.2 Clinical implications and future directions 
The results from this study have clear implications for clinical practice. First, the 
finding that FXS did not have the same relationships between autism, IU and anxiety 
despite being matched with the CdLS group. This is surprising given that both 
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syndromes are associated with ASD presentations that the same relationships were 
not found. It is important, therefore, not to assume, based on autism presentations in 
different syndromes, that the same relationships will exist between IU and anxiety or 
that the same strategies and interventions targeting these relationships will be equally 
effective across different syndromes. It seems that the relationship between anxiety 
and IU is complex and needs further exploration in FXS to identify whether other 
mediating factors are playing a role. As outlined previously, sensory processing and 
sensitivity has been implicated in ASD and in WS as influencing the relationship 
between IU and anxiety in those disorders. It is possible that the influence of sensory 
processing could account for the lack of a mediating role for IU in FXS. It is possible 
that both sensory processing and IU can predict anxiety in FXS, or that sensory 
processing is mediating the relationship between IU and anxiety in FXS - as seen in 
WS, (Uljarević et al., 2018). This needs further exploration.  
The main clinical implication from this study is that IU is playing a key role in the 
presence of anxiety in CdLS. This means that interventions which target IU may be 
successful in reducing anxiety in people with CdLS. Rodgers et al. (2017) developed 
and trialled a parent-based intervention for children with ASD aimed at increasing 
children’s ‘tolerance of uncertainty’ called ‘Coping with Uncertainty in Everyday 
Situations’ -CUES. The intervention ran as an 8-week parent course including 
psychoeducation about IU, teaching parents to identify factors that may trigger IU 
for their child and teaching parents appropriate strategies to use to increase their 
child’s tolerance of uncertainty. Parents were provided with support and written 
materials weekly to identify strategies and target a specific IU situation. These 
materials incorporated existing, evidence-based materials for working with people 
with ASD such as comic-strip conversations and visual prompts. Evaluation of the 
intervention via parent feedback and questionnaires including the IUS-P indicated 
that parents found the interventions helpful and valued the programme. Outcome 
measures indicated a reduction of IU (measured by the IUS-P). Whilst effect sizes 
were modest, the authors suggest that it would be unrealistic to expect large 
reductions immediately after programme completion especially as the parents trying 
out new strategies would potentially increase IU temporarily in people with autism 
as the new strategies are unfamiliar and uncertain. With that in mind, Rodgers et al, 
(2017) assert that a reduction in IU (albeit small) in the face of increasing 
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uncertainty is promising and points to the future clinical utility of the programme. 
Following this study, Rodgers, Herrema, Honey, and Freeston (2018) developed and 
trialled a direct intervention (CUES-A) for adults with ASD to improve their 
tolerance to uncertainty. The intervention was based on strategies used in the 
Rodgers et al. (2017) parent group but adapted for people with ASD. Participants 
had nine individual sessions of intervention including psychoeducation, learning 
about IU and its relationship with ASD and learning strategies to cope with IU based 
on CBT principles. Initial results indicate the feasibility of the approach and results 
showed promise and that participants valued the intervention.  
The development of the CUES programme is promising and may be useful in people 
with CdLS with mild intellectual disability. Further work is needed to validate the 
efficacy of ‘tolerance to uncertainty’ training using the CUES programme, and it is 
unclear whether children with moderate intellectual disabilities could engage with an 
intervention like this. However, if the CUES programme is found to be helpful for 
children with ASD it would seem logical to suggest that people with CdLS of a 
similar intellectual ability would be able to engage in and find the programme useful. 
This an exciting area for future research to develop and trial interventions to reduce 
anxiety and improve quality of life for people with CdLS and other syndromes.  
In conclusion, this study has demonstrated similar relationships between ASD 
symptomatology, IU and anxiety in CdLS as reported in the ASD population. 
However, the same relationships were not replicated in a matched FXS group. It is 
suggested that there may be other mediating factors implicated in the presence of 
anxiety in FXS.  These results indicate the applicability of IU specific interventions 
in CdLS for anxiety management, but also highlights the need for tailored 
interventions for different syndrome groups. 
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This chapter presents a reflective account of the research process whilst conducting 
the research outlined in chapter two. Throughout this chapter I consider 
‘detachment’ experienced throughout this research process, the differences between 
quantitative and qualitative research and draw parallels with the scientist-practitioner 
position as a Clinical Psychologist 
I have valued the reflective process throughout my clinical training. During my 
clinical placements I have used reflection to consider areas for improvement and to 
identify what I am bringing into the therapeutic relationship. However, my previous 
experience of reflecting during the research process was more limited. Reflecting on 
the research process during my thesis research has helped me to appreciate the 
importance of reflective practice in research, even when conducting quantitative 
research. Ryan and Golden (2006) considered the usefulness of reflection in their 
quantitative research. They acknowledged that, whilst reflection in qualitative 
research is more explicit, with many researchers ‘baring their souls’, quantitative 
research seems to avoid reflexivity (Millen, 1997; Ryan & Golden, 2006). Whilst 
controlling the environment and minimising factors that may affect the research 
process (such as a researcher-participant relationships) are important for validity, 
Ryan and Golden (2006) argue that these complex dynamics still exist and reflecting 
on them is necessary.   Through reflecting on this study’s research process, I was 
able to identify and understand my research experience better, namely why I have at 
times felt a lack of connection, or ‘detachment’ from my project.  
3.2 Detachment  
Initially, I was drawn to this research area due to an already developed interest in 
rare genetic syndromes and learning disabilities. Prior to starting the doctorate, I 
completed a PhD at the University of Birmingham in a research team that focuses on 
understanding behaviour and emotions in rare genetic syndromes. My PhD focussed 
on Cornelia de Lange syndrome and looked at relationships between executive 
function, decision making and anxiety in the syndrome. I enjoyed the research area 
so much that I was keen to collaborate with the same research team for my ClinPsyD 
project.  
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When devising my data collection plan for this project, it was agreed that combining 
my data collection with another ongoing project would maximise the participant 
numbers whilst also reducing the burden of participating on families. If 
questionnaire packs were sent out separately for several projects at once, families 
would have to repeatedly fill in consent forms, demographics questions and it would 
increase the workload for them to participate. Therefore, the questionnaires I wanted 
to include for my research project were put together in a questionnaire pack with 
several other questionnaires for concurrent projects working with the same syndrome 
groups.  This strategy meant that my interactions with participants was somewhat 
limited. I attended two family conferences during which I spoke to families that had 
previously taken part in my PhD research, and I helped recruit participants for the 
face to face assessments for the other ongoing project. However, part-way through 
the data collection process I went on maternity leave and therefore took a hiatus 
from the research process. Data collection was still ongoing throughout my 
maternity leave due to the other projects recruiting and seeing participants for face to 
face assessments (where they also completed questionnaire packs).  
When I returned from maternity leave, I had my data to analyse, so I was in a good 
position to move forward. However, I reflected with a fellow trainee that I just was 
not feeling the enthusiasm for or connection to my project, even though I had 
devised it myself and felt passionate about helping the families of the syndrome 
groups I had previously worked with for years.  
Reflecting on my experiences, I realised that there were many key differences in my 
experiences of research during my PhD compared to my ClinPsyD research.  
3.3 The importance of connection 
The life of a typical researcher can be a lonely at times. During my PhD experience, 
many of the other PhD students conducting research at the University of 
Birmingham were working alone on their projects, with no other PhD students 
working in the same research area to discuss ideas with or bond with others about the 
difficulties with their projects. In contrast, the research team I was in had at least 
three PhD students per year all working in the same research area and often doing 
data collection together due to the aforementioned practicalities. Whilst projects 
were individual, much of the process, frustrations and day to day work felt 
 93 
collaborative and supported. There were also regular team ‘socials’ and work done 
for the ‘team’ in addition to our PhD projects. Reflecting on this and contrasting it 
with the research process I experienced during my ClinPsyD project, I can see why I 
may have felt detached during this research project. For my current research, 
meetings with research supervisors at Birmingham were done over Skype and email 
due to the practicalities of getting to Birmingham for regular meetings. When I did 
go into Birmingham to conduct my research-related work, the team had completely 
changed in the three years since I was there. Furthermore, due to my nine months of 
maternity leave, my cohort of trainees had finished when I returned to complete my 
final year. I also had a different timetable from my new cohort due returning to the 
course out of sync with their placement structure. Taken together, all of this meant 
that I did not have the same connection or relationship with my fellow trainees or 
with the research team in Birmingham. This further compounded my experiences of 
feeling detached from my project (as well as my year group). I have realised that a 
sense of belonging and connection is very important to me, as well as having 
relationships and a source of support from my peers and colleagues. I can liken this 
to working in an MDT in clinical settings. Within an MDT setting, you have 
colleagues to bounce ideas off, express frustration to and learn from. This is 
something I have really valued throughout my clinical training and something I 
missed whilst conducting my research.  
Furthermore, whilst the main methodology throughout my PhD thesis was 
quantitative, with a heavy focus on operationalised, objective behavioural measures, 
what actually made me so passionate about the research and so motivated to do it 
was the human element. During my PhD, I had a lot of contact with the participants 
in my studies. I conducted face to face assessments, attended family conferences 
where I spoke with families and presented my findings and I visited participants at 
their homes to conduct some of my assessments if their anxiety was too high to come 
to the research centre.  Whilst I used some questionnaire data in my studies, I could 
put faces and names to the data I analysed as I had interacted with my participants, I 
knew their stories and their struggles. I knew the people behind the data. This 
reflection made me consider my need for the qualitative element with quantitative 
research.  
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3.4 Quantitative versus Qualitative methods 
Quantitative research is traditionally concerned with reducing phenomena to 
‘empirical indicators’ which represent an ‘objective reality’ (Sale, Lohfeld, & Brazil, 
2002). The researcher and participants- or ‘the researched’ are considered to be 
separate entities and therefore the researcher can investigate a phenomenon without 
either being influenced by it or influencing it (Sale et al., 2002). Data are 
operationalised, objective and steps are taken to reduce bias as far as possible. From 
my perspective, prior to clinical training I identified very much as a ‘scientist’. I 
liked the position of ‘knowing’ and running statistical analysis felt exciting and 
satisfying, being able to see patterns in data and understanding a concept better as a 
result of those data. This feels ironic to reflect on now, as my clinical research 
project was about intolerance of uncertainty, and I liked the ‘certainty’ of 
quantitative data myself.  
In contrast, qualitative research is centred around interpretivism (Sale et al., 2002). 
Multiple realities exist based on one’s own construction of this reality. Furthermore, 
reality is socially constructed and therefore changeable (Golafshani, 2003). 
Qualitative research accepts and acknowledges the role of the researcher within the 
research process and sees the relationship between the researcher and participants as 
integral to the study’s findings. Data collection is usually by in-depth interviews or 
focus groups and sample sizes are usually small. The data are not meant to be 
representative of the wider population. In my year’s cohort of eleven trainees, only 
two of us conducted studies using quantitative methods. This seems to be a 
consistent pattern across year groups with a greater focus on qualitative methods. 
When thinking about this, I wonder whether it is because, as clinicians, qualitative 
methods feel more familiar. As clinicians, we are taught about how the ‘relationship’ 
with the client is the most important factor contributing to successful outcomes 
(Blow, Sprenkle, & Davis, 2007; Falkenström, Granström, & Holmqvist, 2013). We 
have many training days working on being able to build that connection with our 
clients, to listen in an empathetic way, reflect how they are feeling and provide a safe 
containing space for them to talk. In many ways, I think that a qualitative approach 
to research draws on a lot of these skills. It is about gaining a deep understanding of 
a particular issue with a participant. You often have to think about how to manage a 
participant’s distress, as the topic of the interview can be emotive.  
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Prior to clinical training I felt rather dismissive of qualitative research, it did not 
seem like ‘science’ to me and felt rather ‘fluffy’. The focus of the research centre 
was on quantitative methodology and so my understanding or appreciation of 
qualitative methods was not developed during my PhD. Whilst I did carry out an 
interview study (with parents of children with Cornelia de Lange syndrome about 
decision making behaviour), I made it ‘quantitative’ by using some fixed answer 
responses and then any free responses from participants were synthesised into tables 
and flow diagrams to describe sequences of behaviours. Looking back, I think I felt 
that I had to pick one approach over the other, a phenomenon described by 
Onwuegbuzie and Leech (2005) rather than considering the possibility of using 
mixed methods. As I had never carried out a qualitative study, I also lacked 
confidence to try one for my ClinPSyD project. Furthermore, I considered a 
quantitative approach to be more ‘useful’ for the families of the syndromes I work 
with. Many of the phenotypic behaviours seen in Cornelia de Lange syndrome are 
not well described or understood. I considered it important to be able to collect as 
much objective data as possible that could be generalised to the CdLS population, 
rather than a qualitative study which, in my view, would not further our 
understanding in a way that allowed the development of interventions.  
It is interesting that I was so fixed on the idea of doing quantitative research that I 
did not consider any alternative projects or using a qualitative approach. During 
clinical training whilst I was being encouraged to consider alternative hypotheses, 
formulations and approaches in my clinical work, I remained welded to my 
quantitative, ‘scientific’ approach to research.  
Onwuegbuzie and Leech (2005) considered the differences between quantitative and 
qualitative methodologies and discussed the importance of using a mixed methods 
approach. They highlighted the division between quantitative and qualitative 
researchers and the assertions of Howe (1988) who states that the two research 
approaches cannot and should not be mixed. Sieber (1973) suggested that both 
approaches have strengths and weaknesses, and as such we should use the strengths 
of both techniques to deepen our understanding of social phenomena. Sieber (1973) 
pointed out that the two dominant paradigms have resulted in two ‘research 
subcultures’ (Onwuegbuzie & Leech, 2005), with qualitative supporters extolling the 
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virtues of ‘deep, rich observational data’ and quantitative supporters, the superiority 
of ‘hard, generalizable data’.   
Onwuegbuzie and Teddlie (2003) suggest that we should move from quantitative vs 
qualitative divides and reframe research as ‘exploratory’ and ‘confirmatory’ 
methods. This concept would bring together both quantitative and qualitative 
methodology under the same framework. Exploratory methods can be quantitative, 
using descriptive statistics and exploratory factor analysis, or qualitative using 
thematic analyses. Confirmatory methods can also be quantitative, using inferential 
statistics and qualitative using ‘confirmatory’ thematic analyses where studies are 
conducted to replicate previous emergent themes or to test a theory (Onwuegbuzie & 
Teddlie, 2003). Reflecting on this, I think this way of thinking would have helped 
me to consider qualitative methods and be more open to them earlier in my thesis 
research journey, even if I still decided that quantitative methodology was more 
fitting for my research questions.  
Without realising it, my research philosophy had become more in line with a ‘mixed’ 
method approach over the course of my PhD, and I struggled to work within a purely 
quantitative and data-driven context for my ClinPsyD project. Whilst considering 
what left me feeling detached and unenthused about my research, I realised that it is 
about the relationship for me and about seeing the applicability of my research and 
the difference it might make to real people. I remembered that, during my 
undergraduate degree, I never thought I wanted to do research. I realise now that this 
is because my experience of research during undergraduate studies were the type of 
studies with minimal participant interaction and limited scope for thinking about 
clinical implications of the work.  It was seeing how much difference research can 
make to the families and people with the rare genetic syndromes that made me feel 
passionate about the research and inspired to do more. 
This realisation that I work well using quantitative methods but also need the 
qualitative element has parallels with my clinical work, and made me consider the 
scientist-practitioner position  
3.5 Scientist- practitioner position 
The definition of ‘scientist-practitioner’ has been debated in the literature. Some 
authors suggest it is about clinicians also contributing to academic research 
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(Kennedy & Llewelyn, 2001) however, sources suggest the majority of Clinical 
Psychologists do not publish their research (Pilgrim & Treacher, 1992; Richardson, 
2014). This could possibly reflect the separation of academic and practitioner 
psychologists (Kennedy & Llewelyn, 2001). An alternative definition of a scientist-
practitioner is a clinician that is engaged with current research and puts this into 
practice in their clinical work (Kennedy & Llewelyn, 2001; Richardson, 2014) 
When talking to fellow trainees about their qualitative research projects, they spoke 
about finding it difficult to be in the ‘researcher’ position instead of being a clinician 
when conducting their research interviews. It was difficult for them to let go of the 
clinical instincts to help and support and instead focus on the research protocols. 
When starting this research project, I considered my identity as both a researcher and 
as a clinician, a scientist and a practitioner. One of my main motivations for carrying 
out this research is that I could see the real-world applicability of the work, I was 
aware of the implications for clinical practice and this is why it felt so important. I 
think that my research project taking a quantitative approach helped me to stay in the 
‘researcher’ position more easily than my fellow trainees, although I missed the 
clinician role in doing so.  
When I commenced clinical training, I had just finished training as a ‘psychological 
wellbeing practitioner’(PWP), using CBT-based interventions with clients mainly 
over the phone. I started the ClinPsyD course a fervent believer in cognitive 
behavioural therapy, and feeling that psychodynamic approaches were a bit ‘fluffy’ 
and I could not get a firm grasp on what exactly they were. On reflection, I can draw 
parallels here with my approach to quantitative versus qualitative methods. In my 
mind, CBT had the most ‘evidence’ for its use with common mental health 
difficulties. It was also structured and straightforward and just ‘made sense’. 
However, I had not enjoyed my work as a PWP due to the very high workload 
pressures, the intense focus on outcome measures and targets and the intervention 
delivery being primarily telephone-based. When starting clinical training, I found 
myself initially sceptical about working psychodynamically, yet over time something 
pulled me towards that way of working.  I saw first hand how powerful building 
relationships with clients could be, and when asked to work in a purely CBT 
approach again during my second year, I found myself pushing against it. I think this 
process reflects both my experiences working in a quantitative way during my 
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research project, and also the struggle to find a happy medium between being a 
scientist and a practitioner. Whilst initially I was focussed on quantitative data, and 
CBT that felt more ‘scientific’ as it had a set protocol, I started to appreciate more 
qualitative ways of working, and drawing on what was happening ‘in the room’ as a 
practitioner.  
In the same way I aligned myself with research that was quantitative but has the 
human connection ‘qualitative’ element, in my clinical practice I enjoyed working in 
a cognitive analytic therapy approach (Ryle, Poynton, & Brockman, 1990) with my 
clients. It has a mix of being structured and focussed whilst also placing high 
importance on the relationship and connection with the client, and seeing what 
comes up in the room. It was only when reflecting on the research process for this 
study that I identified the similar process I went through during my clinical training.  
3.6 Conclusion 
Reflecting on the whole research process, this experience has helped me to identify 
the kind of research I want to do in the future, and but also the kind of clinician I 
want to be. I value quantitative methods and using statistical analyses and the 
‘certainty’ of these approaches, however I need the human connection with my 
participants and the data in order to feel excited about the research. Likewise, in my 
clinical work I like having some structure and using the evidence base to inform my 
work with clients, whilst also using my connection and more qualitative information 
to bring about change. It was only through reflecting on this experience that I can see 
how much I have changed and developed throughout this process and what common 
themes arose throughout my clinical training. Finding a balance between qualitative 
and quantitative approaches and being a scientist and a practitioner is difficult and 
probably one I will continue to juggle. However, as both a clinician and a researcher, 
I have concluded that, for me at least, connection is key.  
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Intolerance of Uncertainty Scale Parent Version 
 
ID Number:                                                               Date: 
 
Below is a series of statements. Please use the scale to describe to what 
extent each item is like your child. Please enter a number (1-5) that 
describes them best. 
 
1 = Not at all like them; 3 = Moderately like them; 5 = Entirely like 
them. 
 
1. When things happen suddenly, s/he gets very upset 
 
 
2. It bothers him/her when there are things they don’t know 
 
 
3. S/he would think that “People should always think about what will  
happen next. This will stop bad things from happening” 
 
 
4. S/he would think that “Even if you plan things really well, one  
little thing can ruin it” 
 
 
5. S/he always want to know what will happen to them in the future 
 
 
6. S/he can’t stand it when things happen suddenly  
 
 
7. S/he needs to always be prepared before things happen 
 
 




9. When s/he’s not sure what to do they freeze  
 
 




11. The smallest worry can stop them from doing things 
 
 








Anxiety Scale for Children with Autism Spectrum Disorder (ASC-ASD) 
Name of child:_______________________________  Age of Child 
(years/months):____________  
Date:____________       Relationship to 
Child:____________  
 
Please put a circle around the word that shows how often each of these 
things happens for your child. 
1. My child suddenly gets a scared feeling when 
there is nothing to be afraid of  Never Sometimes Often Always 
2. My child worries what other people think of 
him/her e.g. that he/ she is different  Never Sometimes Often Always 
3. My child’s heart suddenly starts to beat too 
quickly for no reason  Never Sometimes Often Always 
4. My child feels scared when taking a test in 
case they make a mistake or don’t understand 
the questions  
Never Sometimes Often Always 
5. My child worries that people will bump into 
him/ her or touch him/ her in busy or crowded 
environments  
Never Sometimes Often Always 
6. My child is afraid of being in crowded places 
(like shopping centres, the movies, buses, busy 
playgrounds) in case he/ she is separated from 
his/ her family  
Never Sometimes Often Always 
7. My child worries about doing badly at school 
work  Never Sometimes Often Always 
8. My child suddenly feels so anxious he/ she 
feels as if he/she can't breathe when there is no 
reason for this  
Never  Sometimes  Often  Always  
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9. My child is afraid of new things, or new people 
or new places  Never  Sometimes  Often  Always  
10. My child is afraid of entering a room full of 
people  Never  Sometimes  Often  Always  
11. My child worries when in bed at night 
because he/ she does not like to be away from 
his her parents/ family  
Never  Sometimes  Often  Always  
12. When my child has a problem, he/she feels 
shaky  Never  Sometimes  Often  Always  
13. My child suddenly starts to tremble or shake 
when there is no reason for this  Never  Sometimes  Often  Always  
14. Feeling unsure stops my child from doing 
most things  Never  Sometimes  Often  Always  
15. My child worries when he/she thinks he/she 
has done poorly at something in case people 
judge him/ her negatively  
Never  Sometimes  Often  Always  
16. My child always needs to be prepared before 
things happen  Never  Sometimes  Often  Always  
17. My child feels afraid that he/she will make a 
fool of him/herself in front of people  Never  Sometimes  Often  Always  
18. My child worries about being away from me  Never  Sometimes  Often  Always  
19. My child worries that something awful will 
happen to someone in the family  Never  Sometimes  Often  Always  
20. My child feels scared to be away from home 
because his/ her parents are familiar with his/ 
her bedtime routine  
Never  Sometimes  Often  Always  
21. My child worries about being in certain 
places because it might be too loud, or too bright 
or too busy  
Never  Sometimes  Often  Always  
22. My child suddenly becomes dizzy or faint Never  Sometimes  Often  Always  
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when there is no reason for this  
23. My child worries if they don’t know what will 
happen next e.g. if plans change  Never  Sometimes  Often  Always  
24. My child worries that something bad will 










S:\MIND\RESEARCH\Abbeduto\FX Longitudinal Adult (FXLA)\Protocol Instructions 
 
Date: _____________                                                                                ID: _________________ 
Instructions:  Please describe your child’s behavior over the last 6 months using the ratings and list 
of behaviors below. 
 
0 behavior has not occurred, or is not a problem 
1 behavior occurs occasionally, or is a mild problem 
2 behavior occurs quite often, or is a moderate problem 
3 behavior occurs a lot, or is a severe problem 
 








1. Nervous . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 1 2 3 
 
2. Problems initiating communication . . . . . . . . . . . . . . . . . .  0 1 2 3 
 
3. Does not relax or settle down . . . . . . . . . . . . . . . . . . . . . .  0 1 2 3 
 
4. Has periods of over-activity . . . . . . . . . . . . . . . . . . . . . . . .  0 1 2 3 
 
5. Sleeps more than normal . . . . . . . . . . . . . . . . . . . . . . . . . .  0 1 2 3 
 
6. Withdraws from other people . . . . . . . . . . . . . . . . . . . . . .  0 1 2 3 
 
7. Tense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 1 2 3 
 
8. Engages in ritualistic behaviors . . . . . . . . . . . . . . . . . . . . .  0 1 2 3 
 
9.  Depressed mood . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 1 2 3 
 
10. Sad . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 1 2 3 
 
11. Worried . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 1 2 3 
 
12. Has developed difficulty staying on task or 
completing work . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
0 1 2 3 
 
13. Shy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 1 2 3 
 
14. Easily fatigued (not due to being overweight). . . . . . . . . . 0 1 2 3 
 
15. Anxious . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 1 2 3 
 
16. Repeatedly checks items . . . . . . . . . . . . . . . . . . . . . . . . . 
 
0 1 2 3 
17. Easily distracted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
 
0 1 2 3 
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Understanding Behaviour, Emotion and Movement in Individuals with 
[insert syndrome] 
 
Information Sheet  
 
Please read this information carefully before deciding whether you wish to take part 
in the study. If you have any further questions please contact Laura Groves 
(Doctoral Researcher) by telephone:   , email: 
; or Dr Hayley Crawford (Postdoctoral Research 
Fellow) by telephone: , email: . If 
you have any medical/other problems which make it difficult for you to read this 
information, please contact Laura Groves or Hayley Crawford for a verbal 
explanation of the research. 
 
You can watch a short film about this research project on our website at: [insert web 
address] 
 
When you are happy that you have all of the information you need to be able to 
decide whether or not you and the person you care for would like to take part in the 
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study, please complete the enclosed consent form and return it to us in the prepaid 
envelope provided. If you’d prefer to, you can complete the consent forms online 
using [insert link] and entering the password ‘cerebra’.  
 
Background 
We would like to invite you and your child/person you care for to take part in a study 
being conducted at the Cerebra Centre for Neurodevelopmental Disorders, 
University of Birmingham in collaboration with Coventry University. This research 
work, which is led by Professor Chris Oliver, looks at behaviour, emotion and 
movement in individuals with [insert syndrome].  
 
We hope that this information will enable us to further understand what difficulties 
individuals with [insert syndrome] experience, as well as any associated factors. 
This in turn will contribute towards a better understanding of the syndrome and 
more targeted intervention strategies in order to improve the well-being of 
individuals and their families. The more people that take part in this research, the 
more meaningful the results will be. A good response will provide new and valuable 
information about [insert syndrome].   
 
Aims of the study 
1. What are the behavioural or emotional difficulties experienced by individuals 
with [insert syndrome]? 
2. What is the association between these and cognitive and motor skills in 
individuals with [insert syndrome]? 
3. How do behaviours, cognition and motor skills develop and change with 
age?  
4. Are different genetic mechanisms associated with different profiles of 
behaviour, cognition and motor skills? 
 
What will happen if you and your child/the person you care for decide(s) to 
participate? 
 
Where will the research take place? 
The research will be conducted at the Cerebra Centre for Neurodevelopmental 
Disorders at the University of Birmingham, at the participant’s home, or at [insert 
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syndrome support group] conferences if this is preferred. We will ask your 
child/person you care for to take part in table top activities and some movement 
tasks. We will also want to ask you some questions however this can be completed 
over the telephone before the assessment day if this is more convenient.  
 
 
Who will be involved in collecting the data? 
Members of the research team at the Cerebra Centre for Neurodevelopmental 
Disorders and at Coventry University, including Laura Groves and Hayley Crawford. 
 
How long will participation in the study take? 
The assessment day will take approximately 3-4 hours with breaks included. The 
following gives you an approximation of how long each individual session of the 
assessment day may take. Please note, these are estimates and actual timings may 
vary. 
• Assessment of level of ability – from 40 mins to 1hr 20mins 
• Cognitive assessments – 40 mins 
• Assessments of behaviour – 20 mins 
• Movement assessments – 20 mins 
 
What will participants be required to do during the study? 
On the assessment day, we may ask you to complete some 
interviews/questionnaires and to be present during your child’s/person you care 
for’s assessments. Your child/person you care for will be asked to complete some 
table top activities and movement tasks (e.g. walking, reaching for objects). Breaks 
will be included. During the movement tasks we will ask your child/person you care 
for to wear movement sensors on their wrists, ankles and around their middle. The 
sensors are about the size of a wristwatch and are attached with fabric straps. They 
should not cause discomfort.  
 
We will also want to interview you about your child/person you care for which will 
take approximately 2hrs 30mins in total; however, this can be divided into smaller 
 124 
time segments and completed over multiple sessions if this is more convenient. 
Additionally, these can be completed over the telephone or on the assessment day 
if you prefer. We will also ask you to complete some questionnaires about your 
child/person you care for (approx. 45 minutes). As there are multiple aspects to this 
study (i.e. behaviour, cognition, movement), there is an option to only participant in 
some parts of the study if you would prefer. 
 
During the visit we will also ask your child/person you care for to provide two saliva 
samples for cortisol analysis. Cortisol is a hormone released when an individual 
becomes stressed; by measuring this we can assess the level of stress your 
child/person you care for may be feeling. These will be collected either by placing 
an absorbent swab inside the cheek and leaving it there for 1-2 minutes, or by 
placing a swab under the tongue for 60-90 seconds. These methods are non-
invasive, painless and have been used widely in intellectual disability research.  
 
If you are happy and your child/the person you care for are happy to do so we will 
also ask for a third saliva sample to be taken for genetic analysis. This sample can 
be taken before, during, or after the assessment day and returned to us using a pre-
paid envelope, which we will provide you with. The genetic information extracted 
from this saliva sample will be used to identify genetic variation that might be 
important in understanding causes and consequences of [insert syndrome]. Please 
note that we will be unable to provide feedback regarding the results of the genetic 
analysis, although you will receive feedback on all other aspects of the study. If you 
or the person you care for decide you would prefer not to provide this sample, we 
would like to ask your permission to contact your G.P or consultant to request 
written confirmation of the genetic diagnosis. It is entirely up to you and/or the 
person you care for whether you give us permission to do either of these and 
choosing not to do so will not impact on your participation in the study.   
 
Although not required, your child/person you care for may drink water or brush their 
teeth with water before the collection. In the case that your child/person you care for 
has eaten a meal before the procedure, they will need to wait 15–20 minutes after 
feeding before collecting the saliva sample. Because genetic information varies 
across individuals with differing ancestral backgrounds, we may also ask you to 





Will assessments/interviews be recorded?  
 
During the assessments, your child/person you care for’s behaviour and the 
behaviour of people in their immediate surroundings will be recorded using a video 
camera. We will also take an audio recording when we interview you about your 
child/the person you care for. These recordings will be used in order to check the 
accuracy of these assessments with another researcher. 
 
The University of Birmingham will hold the copyright for the audio/video recordings 
so that the confidentiality of these recordings will be protected. But, the University of 
Birmingham will not be able to edit or use the recordings for teaching purposes 
unless you give us your written permission to do this.  
 
We may contact you again in the future to ask your permission to use some of the 
recordings for teaching purposes. At that time you will be able to decide whether or 
not you are happy for the recordings to be used for these purposes. Agreeing to 
participate in this study does not mean that you will have to give your permission for 
the use of these recordings in the future. 
 
Are there any risks that individuals taking part in the study might face? 
There is some risk that emotional upset may be caused from your child/person you 
care for taking part in some of the assessments. However, it is unlikely that these 
will be issues that they do not face in their daily life. Nonetheless, this may still be 
an upsetting experience for them. If distress is noticed we will stop immediately, and 
cease all assessments if required.  
 
There are no known risks associated with saliva collection procedures, although 
your child/person you care for may not like having to provide his/her saliva sample 
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in the kit. You will be free to withdraw from this at any time, including if your 
child/person you care for becomes upset or unhappy.  
 
Will I be able to withdraw from the research? 
Should you or the person you care for decide that you no longer wish to be involved 
in the research; you are free to withdraw your participation at any time during the 
study and for a period of three months after the data collection with yourselves has 
been completed. If you decide to do so, information that you have provided in this 
time can also be withdrawn and destroyed without you giving reason. This will not 
restrict access to other services and will not affect the right to treatment. 
 
If you/ the person you care for decide(s) to participate, what will happen after 
that participation? 
 
You and your child/ person you care for will receive an individual feedback report 
describing the results of all of the assessments that were carried out during the 
study. Unfortunately, we will not be able to feedback the results of the genetic 
analysis to you, including information regarding other genetic variations not related 
to the study. A summary of the overall project’s findings will be circulated to anyone 
involved who wishes to see a copy. Any requests for clinical advice concerning your 
child/person you care for will be referred to Professor Chris Oliver, Clinical 
Psychologist. 
 
Descriptions of research findings will be published in newsletters of the [specific 
syndrome support group], family support groups and educational institutions 
involved. The researchers will publish the findings from the study in scientific 
journals and will present the results at relevant research conferences. All published 
data will be anonymous without names or other identifying information. 
 
Where will data be stored? 
The information that you provide will be locked in a filing cabinet at the University of 
Birmingham or held on a password protected database/hard drive. Only members of 
the research team at the University of Birmingham will have access to the 
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information that we collect about you. Information will be treated as strictly 
confidential and handled in accordance with the provisions of the Data Protection 
Act 1998. All personal details will be kept separately from the information collected 
and your child/person you care for will be identifiable by a unique number 
throughout the study to ensure information you provide us with cannot be traced to 
your personal details. If published, information will be presented without reference 
to any identifying information.  
 
You will be able to decide whether or not you want to make your research data 
available to any professionals or clinicians working with you and the person you 
care for should they wish to see it. This is optional and will not affect your 
participation in the current study. If you agree to this, then your research data will 
only be made available to relevant clinicians or professionals should they contact us 
directly and request to see it. If you do not agree to this then research data will not 
be made available to anyone other than the research team at the University of 
Birmingham. 
 
Your child’s/person you care for’s saliva sample for genetic testing will be stored 
and processed by genetic laboratories headed by Dr Jane Steele and Mr Andrew 
Beggs. These centres are based at the University of Birmingham and will not be 
provided with your child’s/person you care for’s personal information. Saliva 
samples for cortisol analysis will be stored and processed by the laboratory based 
at Coventry University, led by Professor Derek Renshaw. Again, this centre will not 
be provided with your child’s/person you care for’s personal information. Only 
researchers directly involved in this study will have access to this personal 
information, which will be stored on a password protected database.  
 
In any description of research findings that we might publish, we will not include any 
information that will make it possible to identify a participant. Research data 
obtained from saliva samples collected during this study will be held indefinitely for 
use in potential follow up publications as well as in other associated studies 
conducted within the research team, including genetic testing.  
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Unknown participants: After 6 months of receiving your questionnaire pack, your 
personal details will be destroyed unless you tell us otherwise.  This means that 
we would no longer be able to trace the results of your assessments back to you.  
The section below on ‘The Regular Participant Database Information’ gives 
information about a database that we use to store the personal details of some 
participants.  Please read this section in order to decide if you would like to join that 
database.  
 
If participant is known to us already and has previously agreed for us to keep 
their details and contact them for future research: Since you have previously 
been involved in our research projects at the University of Birmingham and have 
agreed to be contacted by the research team with information about future research 
work, we have a copy of your personal details on the ‘Regular Participant 
Database’. This database is password protected and only approved members of our 
research team have access to your details.  We do not share your details with 
anyone outside the research team. 
 
What happens if I decide that I no longer want my details on the Regular Participant 
Database? 
All you would need to do is contact Chris Oliver on  or at 
 or at the School of Psychology, University of Birmingham, 




Regular Participant Database Information: 
 
What is the regular participant database? 
We have a database that we keep in the Cerebra Centre where we store the names 
and contact details of some previous participants.  If you would like us to, we can 
add your details to this database.  We would use this information for two things: 
1) We will contact you with information about future research work to find out 
whether or not you would like to participate. 
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2) It is often important to find out how things change over time. By keeping your 
details we would be able to trace the results of the previous assessments 
that you have done with us back to you.  This means that if you take part in 
other studies with us we would be able to look at how things have changed 
over time. 
 
Who would have access to my details? 
Only approved members of out research team would have access to your details.  
We would not share your details with anyone outside the research team. 
 
When would I be contacted? 
You would only be contacted by an approved member of the research team when 
we are starting another study or phase of a study that we think you might like to 
participate in or when we need to clarify some information that you have provided 
us with from participation in a research study.  
 
What happens if I decide that I want my details to be added to the database 
but then I change my mind? 
All you would need to do is contact Chris Oliver on  or at 
 or at the School of Psychology, University of Birmingham, 




After having read all of the information and having received appropriate responses 
to any questions that you may have about the study you and the person you care 
for will be asked to give your and your child’s/ person you care for’s consent to 
participate in the study if you decide that you do wish to participate.  The section 
below on ’Giving consent’ will explain this process.  We need to receive consent 
from/ on behalf of potential participants in order for them to participate. 
 
Withdrawal 
Even after consent has been granted, participants can request to be withdrawn from 
the study at any time, without giving a reason. Even after participation has taken 
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place, consent can be withdrawn and any data collected will be destroyed.  This will 
not restrict the access of you/ the person you care for to other services and will not 
affect their right to treatment. 
 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak to the 
researchers who will do their best to answer your questions. Please contact Chris 
Oliver on  or at  in the first instance. If you 
remain unhappy and wish to complain formally, you can contact: Professor Kim 
Shapiro; Head of School; School of Psychology, University of Birmingham, 
Birmingham, B15 2TT, by email:   or by 
phone on . 
 
Making a complaint  
If you would like to make a complaint about this research please contact the Patient 
Advice and Liaison (PALS) office. The Birmingham PALS office can be contacted 
on 0121 371 3280. Alternatively, you can search for your local PALS office by going 
to http://www.nhs.uk/chq/pages/1082.aspx?CategoryID=68, by contacting your GP 
surgery/hospital, or by phoning NHS 111. 
 
Confidentiality                  
The confidentiality of participants will be ensured.  If published, information on the 
participant will be presented without reference to their name or any other identifying 
information.  All personal details will be kept separately from the information 
collected so that it will only be possible to connect results to individuals via a special 
code. This will ensure that results are kept anonymous.  In the unlikely event of any 




The study has been approved by (name) NHS Research Ethics Committee. Contact 
details and ref number 
 
Further information 
If you would like any more information about the study please contact Laura Groves 
(Doctoral Researcher) by telephone: , email: 
; or Hayley Crawford (Postdoctoral Research Fellow) 





You need to decide whether your child/the person you care for is able to understand 
enough about the study to make an ‘informed’ decision independently about whether 
or not they would like to participate and to communicate this decision to you.  If you 
are unsure whether or not your child/person you care for is able to understand enough 
to make a decision independently then we can provide you with some guidelines to help 
you to assess this. A symbol information sheet can also be made available to you if this 
would be of help.  
 
Please contact Laura Groves ; or Hayley 
Crawford  to request a copy.  
Now it is up to you whether you decide that you and your child/the person you care 
for would like to participate. The decision about whether or not to take part in the 
study must be ‘informed’.  This means that anyone making the decision must 
understand exactly what is involved in the study, what will be required from 
participants and why.   
 
Please choose from one of the following options: 
 
 
1. My child/ the person I care for is able to understand what 
is involved in the study and what will be required from 
them if they participate and has communicated their 
decision to me: 
 
If you think that the person is is able to understand enough about the study in order 
to make an ‘informed’  
decision and they decide that they would like to participate then please ensure that 
they complete Section 1 of Consent Form A coloured YELLOW enclosed, or that 
you complete it with them, on their behalf.  A parent/carer will need to complete 
Section 2 of Consent Form A coloured YELLOW in order to indicate that they 
also agree to participate in the study. A symbol information sheet can be made 
available in order to support your child/person you care for in making this decision if 
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it would be of help. Please contact the research team if you would like a copy of the 
symbol consent form or if you need us to adapt this information further, in order to 
suit your child’s needs. Please return the consent form along with the questionnaire 
pack to us in the prepaid envelope provided. You can also complete this online 
[insert link] using the password ‘cerebra’.   
 
 
2. My child/ the person I care for is unable to understand 
what is involved in the study and what will be required 
from them if they participate (either because they are too 
young to understand or because they are unable to 
understand) and  cannot communicate their decision to 
me: 
 
If you are reading this information on behalf of someone you care for who is under 
the age of 16 years and you decide that the person is not able to make an 
‘informed’ and independent decision about whether or not they would like to 
participate, then we would like to ask you to decide whether or not you think that it is 
in your child’s best interests for them to participate in the study and whether you 
would like to provide your consent to participation on their behalf. If you would like 
your child/person you care for to participate in this study, please complete Consent 
Form B coloured PURPLE enclosed. Please return the consent form along with 
the questionnaire pack to us in the prepaid envelope provided. You can also 
complete this online [insert link] using the password ‘cerebra’.   
 
 
Thank you very much for taking the time to read this information – please 









      
Understanding Behaviour, Emotion and Movement in Individuals with 
[insert syndrome] 
 
Information Sheet  
 
Please read this information carefully before deciding whether you wish to take part 
in the study. If you have any further questions please contact Laura Groves 
(Doctoral Researcher) by telephone:   , email: 
; or Dr Hayley Crawford (Postdoctoral Research 
Fellow) by telephone: , email: . If 
you have any medical/other problems which make it difficult for you to read this 
information, please contact Laura Groves or Hayley Crawford for a verbal 
explanation of the research. 
 
You can watch a short film about this research project on our website at: [insert web 
address] 
 
When you are happy that you have all of the information you need to be able to 
decide whether or not you and your child/the person you care for would like to take 
part in the study, please complete the enclosed consent form and return it to us in 
the prepaid envelope provided. If you’d prefer to, you can complete the consent 




We would like to invite you and your child/person you care for to take part in a study 
being conducted at the Cerebra Centre for Neurodevelopmental Disorders, 
University of Birmingham in collaboration with Coventry University. This research 
work, which is led by Professor Chris Oliver, looks at behaviour, emotion and 
movement in individuals with [insert syndrome].  
 
We hope that this information will enable us to further understand what difficulties 
individuals with [insert syndrome] experience, as well as any associated factors. 
This in turn will contribute towards a better understanding of the syndrome and 
more targeted intervention strategies in order to improve the well-being of 
individuals and their families. The more people that take part in this research, the 
more meaningful the results will be. A good response will provide new and valuable 
information about [insert syndrome].   
 
Aims of the study 
5. What are the behavioural or emotional difficulties experienced by individuals 
with [insert syndrome]? 
6. What is the association between these and cognitive and motor skills in 
individuals with [insert syndrome]? 
7. How do behaviours, cognition and motor skills develop and change with 
age?  
8. Are different genetic mechanisms associated with different profiles of 
behaviour, cognition and motor skills? 
 
What will happen if you and your child/the person you care for decide(s) to 
participate? 
 
Where will the research take place? 
The research will be conducted at the Cerebra Centre for Neurodevelopmental 
Disorders at the University of Birmingham, at the participant’s home, or at [insert 
syndrome support group] conferences if this is preferred. We will ask your 
child/person you care for to take part in table top activities and some movement 
tasks. We will also want to ask you some questions however this can be completed 




Who will be involved in collecting the data? 
Members of the research team at the Cerebra Centre for Neurodevelopmental 
Disorders and at Coventry University, including Laura Groves and Hayley Crawford. 
 
How long will participation in the study take? 
The assessment day will take approximately 3-4 hours with breaks included. The 
following gives you an approximation of how long each individual session of the 
assessment day may take. Please note, these are estimates and actual timings may 
vary. 
• Assessment of level of ability – from 40 mins to 1hr 20mins 
• Cognitive assessments – 40 mins 
• Assessments of behaviour – 20 mins 
• Movement assessments – 20 mins 
 
What will participants be required to do during the study? 
On the assessment day, we may ask you to complete some 
interviews/questionnaires and to be present during your child’s/person you care 
for’s assessments. Your child/person you care for will be asked to complete some 
table top activities and movement tasks (e.g. walking, reaching for objects). Breaks 
will be included. During the movement tasks we will ask your child/person you care 
for to wear movement sensors on their wrists, ankles and around their middle. The 
sensors are about the size of a wristwatch and are attached with fabric straps. They 
should not cause discomfort.  
 
We will also want to interview you about your child/person you care for which will 
take approximately 2hrs 30mins in total; however, this can be divided into smaller 
time segments and completed over multiple sessions if this is more convenient. 
Additionally, these can be completed over the telephone or on the assessment day 
if you prefer. We will also ask you to complete some questionnaires about your 
child/person you care for (approx. 45 minutes). As there are multiple aspects to this 
study (i.e. behaviour, cognition, movement), there is an option to only participant in 
some parts of the study if you would prefer. 
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During the visit we will also ask your child/person you care for to provide two saliva 
samples for cortisol analysis. Cortisol is a hormone released when an individual 
becomes stressed; by measuring this we can assess the level of stress your 
child/person you care for may be feeling. These will be collected either by placing 
an absorbent swab inside the cheek and leaving it there for 1-2 minutes, or by 
placing a swab under the tongue for 60-90 seconds. These methods are non-
invasive, painless and have been used widely in intellectual disability research.  
 
If you are happy and your child/the person you care for are happy to do so we will 
also ask for a third saliva sample to be taken for genetic analysis. This sample can 
be taken before, during, or after the assessment day and returned to us using a pre-
paid envelope, which we will provide you with. The genetic information extracted 
from this saliva sample will be used to identify genetic variation that might be 
important in understanding causes and consequences of [insert syndrome]. Please 
note that we will be unable to provide feedback regarding the results of the genetic 
analysis, although you will receive feedback on all other aspects of the study. If you 
or the person you care for decide you would prefer not to provide this sample, we 
would like to ask your permission to contact your G.P or consultant to request 
written confirmation of the genetic diagnosis. It is entirely up to you and/or the 
person you care for whether you give us permission to do either of these and 
choosing not to do so will not impact on your participation in the study.   
 
Although not required, your child/person you care for may drink water or brush their 
teeth with water before the collection. In the case that your child/person you care for 
has eaten a meal before the procedure, they will need to wait 15–20 minutes after 
feeding before collecting the saliva sample. Because genetic information varies 
across individuals with differing ancestral backgrounds, we may also ask you to 




Will assessments/interviews be recorded?  
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During the assessments, your child/person you care for’s behaviour and the 
behaviour of people in their immediate surroundings will be recorded using a video 
camera. We will also take an audio recording when we interview you about your 
child/the person you care for. These recordings will be used in order to check the 
accuracy of these assessments with another researcher. 
 
The University of Birmingham will hold the copyright for the audio/video recordings 
so that the confidentiality of these recordings will be protected. But, the University of 
Birmingham will not be able to edit or use the recordings for teaching purposes 
unless you give us your written permission to do this.  
 
We may contact you again in the future to ask your permission to use some of the 
recordings for teaching purposes. At that time you will be able to decide whether or 
not you are happy for the recordings to be used for these purposes. Agreeing to 
participate in this study does not mean that you will have to give your permission for 
the use of these recordings in the future. 
 
Are there any risks that individuals taking part in the study might face? 
There is some risk that emotional upset may be caused from your child/person you 
care for taking part in some of the assessments. However, it is unlikely that these 
will be issues that they do not face in their daily life. Nonetheless, this may still be 
an upsetting experience for them. If distress is noticed we will stop immediately, and 
cease all assessments if required.  
 
There are no known risks associated with saliva collection procedures, although 
your child/person you care for may not like having to provide his/her saliva sample 
in the kit. You will be free to withdraw from this at any time, including if your 
child/person you care for becomes upset or unhappy.  
 
Will I be able to withdraw from the research? 
Should you or the person you care for decide that you no longer wish to be involved 
in the research; you are free to withdraw your participation at any time during the 
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study and for a period of three months after the data collection with yourselves has 
been completed. If you decide to do so, information that you have provided in this 
time can also be withdrawn and destroyed without you giving reason. This will not 
restrict access to other services and will not affect the right to treatment. 
 
If you/ the person you care for decide(s) to participate, what will happen after 
that participation? 
 
You and your child/ person you care for will receive an individual feedback report 
describing the results of all of the assessments that were carried out during the 
study. Unfortunately, we will not be able to feedback the results of the genetic 
analysis to you, including information regarding other genetic variations not related 
to the study. A summary of the overall project’s findings will be circulated to anyone 
involved who wishes to see a copy. Any requests for clinical advice concerning your 
child/person you care for will be referred to Professor Chris Oliver, Clinical 
Psychologist. 
 
Descriptions of research findings will be published in newsletters of the [specific 
syndrome support group], family support groups and educational institutions 
involved. The researchers will publish the findings from the study in scientific 
journals and will present the results at relevant research conferences. All published 
data will be anonymous without names or other identifying information. 
 
Where will data be stored? 
The information that you provide will be locked in a filing cabinet at the University of 
Birmingham or held on a password protected database/hard drive. Only members of 
the research team at the University of Birmingham will have access to the 
information that we collect about you. Information will be treated as strictly 
confidential and handled in accordance with the provisions of the Data Protection 
Act 1998. All personal details will be kept separately from the information collected 
and your child/person you care for will be identifiable by a unique number 
throughout the study to ensure information you provide us with cannot be traced to 
your personal details. If published, information will be presented without reference 
to any identifying information.  
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You will be able to decide whether or not you want to make your research data 
available to any professionals or clinicians working with you and the person you 
care for should they wish to see it. This is optional and will not affect your 
participation in the current study. If you agree to this, then your research data will 
only be made available to relevant clinicians or professionals should they contact us 
directly and request to see it. If you do not agree to this then research data will not 
be made available to anyone other than the research team at the University of 
Birmingham. 
 
Your child’s/person you care for’s saliva sample for genetic testing will be stored 
and processed by genetic laboratories headed by Dr Jane Steele and Mr Andrew 
Beggs. These centres are based at the University of Birmingham and will not be 
provided with your child’s/person you care for’s personal information. Saliva 
samples for cortisol analysis will be stored and processed by the laboratory based 
at Coventry University, led by Professor Derek Renshaw. Again, this centre will not 
be provided with your child’s/person you care for’s personal information. Only 
researchers directly involved in this study will have access to this personal 
information, which will be stored on a password protected database.  
 
In any description of research findings that we might publish, we will not include any 
information that will make it possible to identify a participant. Research data 
obtained from saliva samples collected during this study will be held indefinitely for 
use in potential follow up publications as well as in other associated studies 
conducted within the research team, including genetic testing.  
 
Unknown participants: After 6 months of receiving your questionnaire pack, your 
personal details will be destroyed unless you tell us otherwise.  This means that 
we would no longer be able to trace the results of your assessments back to you.  
The section below on ‘The Regular Participant Database Information’ gives 
information about a database that we use to store the personal details of some 




If participant is known to us already and has previously agreed for us to keep 
their details and contact them for future research: Since you have previously 
been involved in our research projects at the University of Birmingham and have 
agreed to be contacted by the research team with information about future research 
work, we have a copy of your personal details on the ‘Regular Participant 
Database’. This database is password protected and only approved members of our 
research team have access to your details.  We do not share your details with 
anyone outside the research team. 
 
What happens if I decide that I no longer want my details on the Regular Participant 
Database? 
All you would need to do is contact Chris Oliver on  or at 
 or at the School of Psychology, University of Birmingham, 




Regular Participant Database Information: 
 
What is the regular participant database? 
We have a database that we keep in the Cerebra Centre where we store the names 
and contact details of some previous participants.  If you would like us to, we can 
add your details to this database. We would use this information for two things: 
3) We will contact you with information about future research work to find out 
whether or not you would like to participate. 
4) It is often important to find out how things change over time. By keeping your 
details we would be able to trace the results of the previous assessments 
that you have done with us back to you. This means that if you take part in 
other studies with us we would be able to look at how things have changed 
over time. 
 
Who would have access to my details? 
Only approved members of our research team would have access to your details. 
We would not share your details with anyone outside the research team. 
 
 141 
When would I be contacted? 
You would only be contacted by an approved member of the research team when 
we are starting another study or phase of a study that we think you might like to 
participate in or when we need to clarify some information that you have provided 
us with from participation in a research study.  
 
What happens if I decide that I want my details to be added to the database 
but then I change my mind? 
All you would need to do is contact Chris Oliver on  or at 
 or at the School of Psychology, University of Birmingham, 




After having read all of the information and having received appropriate responses 
to any questions that you may have about the study you will be asked to give your 
and your child’s/ person you care for’s consent to participate in the study if you 
decide that you do wish to participate. The section below on ’Giving consent’ will 
explain this process.  We need to receive consent from/on behalf of potential 
participants in order for them to participate. 
 
Withdrawal 
Even after consent has been granted, participants can request to be withdrawn from 
the study at any time, without giving a reason. Even after participation has taken 
place, consent can be withdrawn and any data collected will be destroyed.  This will 
not restrict the access of you/ the person you care for to other services and will not 
affect their right to treatment. 
 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak to the 
researchers who will do their best to answer your questions. Please contact Chris 
Oliver on  or at  in the first instance. If you 
remain unhappy and wish to complain formally, you can contact: Professor Kim 
Shapiro; Head of School; School of Psychology, University of Birmingham, 
Birmingham, B15 2TT, by email:   or by 
phone on . 
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Making a complaint  
If you would like to make a complaint about this research please contact the Patient 
Advice and Liaison (PALS) office. The Birmingham PALS office can be contacted 
on 0121 371 3280. Alternatively, you can search for your local PALS office by going 
to http://www.nhs.uk/chq/pages/1082.aspx?CategoryID=68, by contacting your GP 
surgery/hospital, or by phoning NHS 111. 
 
Confidentiality                  
The confidentiality of participants will be ensured.  If published, information on the 
participant will be presented without reference to their name or any other identifying 
information.  All personal details will be kept separately from the information 
collected so that it will only be possible to connect results to individuals via a special 
code. This will ensure that results are kept anonymous. In the unlikely event of any 




The study has been approved by (name) NHS Research Ethics Committee. Contact 
details and ref number 
 
Further information 
If you would like any more information about the study please contact Laura Groves 
(Doctoral Researcher) by telephone: , email: 
; or Hayley Crawford (Postdoctoral Research Fellow) 
by telephone: , email: . 
 
Giving consent 
Now it is up to you whether you decide that you and your child/the person you care 
for would like to participate.  The decision about whether or not to take part in the 
study must be ‘informed’.  This means that anyone making the decision must 
understand exactly what is involved in the study, what will be required from 





You need to decide whether your child/the person you care for is able to understand 
enough about the study to make an ‘informed’ decision independently about whether 
or not they would like to participate and to communicate this decision to you.  If you 
are unsure whether or not your child/person you care for is able to understand enough 
to make a decision independently then we can provide you with some guidelines to help 
you to assess this. A symbol information sheet can also be made available to you if this 
would be of help.  
 
Please contact Laura Groves , ; or Hayley 
Crawford ,  to request a copy.  
 
Please choose from one of the following options: 
1. My child/ the person I care for is able to understand what 
is involved in the study and what will be required from 
them if they participate and has communicated their 
decision to me: 
 
If you think that the person is is able to understand enough about the study in order 
to make an ‘informed’ decision and they decide that they would like to participate 
then please ensure that they complete Section 1 of Consent Form A coloured 
YELLOW enclosed, or that you complete it with them, on their behalf.  A 
parent/carer will need to complete Section 2 of Consent From A coloured 
YELLOW in order to indicate that they also agree to participate in the study. A 
symbol information sheet can be made available in order to support your 
child/person you care for in making this decision if it would be of help. Please 
contact the research team if you would like a copy of the symbol consent form or if 
you need us to adapt this information further in order to suit your child’s needs. 
Please return the consent form along with the questionnaire pack to us in the 
prepaid envelope provided. You can also complete this online [insert link] using the 




2. My child/ the person I care for is over the age of 16 and 
cannot understand what is involved in the study or cannot 
communicate their decision to me: 
 
 
If you are reading this information on behalf of someone you care for who is over 
the age of 16 and you decide that the person is not able to make an ‘informed’ 
decision about whether or not they would like to participate, then we would like to 
invite you to act as a ‘personal consultee’ (or ‘nominated consultee’ where an 
unpaid carer e.g. parent, legal guardian etc is not able to act as a ‘personal 
consultee’) for that person.  Please read the enclosed ‘Personal and Nominated 
Consultee Information Sheet’ coloured PINK.  Once you have finished reading the 
‘Personal and Nominated Consultee Information Sheet’ please decide whether or 
not you feel able to act as a personal or nominated consultee for the person you 
care for. 
 
If you feel able to act as a personal or nominated consultee for the person you care 
for please think about whether the person would decide to participate if they were 
able to make an ‘informed’ decision themselves about whether or not to participate.  
If you decide that the person would decide to participate, please complete Consent 
Form C(a) coloured BLUE enclosed and return it to us in the prepaid envelope 
provided. You can also complete this online [insert link] using the password 




Thank you very much for taking the time to read this information – please 








         
 
 
Consent Form A:  For individuals who are able to provide consent to 
participate in the study 
 
Understanding Behaviour, Emotion and Movement in Individuals with [insert 
syndrome] 
 
Study Director: Professor Chris Oliver 
 
SECTION 1:  Please complete this section if you are a person with [insert 
syndrome]: 
 
1. Has somebody else explained the project to you?    
  YES/NO 
2. Do you understand what the project is about?      
  YES/NO 
3. Have you asked all of the questions you want?      
  YES/NO 
4. Have you had your questions answered in a way you understand?   
  YES/NO 
5. Do you understand it is OK to stop taking part at any time?    
  YES/NO 
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6. Are you happy to be video recorded as part of the study?    
  YES/NO 
  
7. Are you happy to take part?        
  YES/NO 
 
If any answers are ‘no’ or you don’t want to take part, don’t sign your name! 
 
If you do want to take part, you can write your name below 
 
You can also choose if you want to say ‘yes’ to these questions:   
         YES NO 
  
8. Do you understand that we may ask you to provide a saliva sample that we will 
use to understand more about the cause of your syndrome/disability. 
 
9. If your Dr asks to see your results from this project is that OK?   
    
10. Are you happy for us to contact you again in the future?    















The person who explained this project to you needs to sign too. If you are under the 
age of 16, this should be your parent/guardian. 
 





SECTION 2: This is optional and allows you to provide consent for us to keep 
your personal details on the Regular Participant Database.  See section titled 
‘Regular Participant Database’ in the information sheet.    
       Please initial box [or online tick] 
… 
1. I have read and understood the section titled ‘Regular Participant 
Database’ and I would like my personal details to be added to the 
database. 
 
2. I understand that my name and contact details will be kept by the 
research team at the University of Birmingham in accordance with the 
provisions of the Data Protection Act 1998 and I will be contacted by an 
approved member of the team with information about future research 
that I and the person I care for may like to participate in. 
 
3. I understand that if my details are held on the database it will be possible 
for the research team to trace the results of the assessments that I 
complete in this project back to me and my child/person I care for so 
that they can look at changes over time if I take part in future projects. 
 
4. I understand that even after I have agreed for my details to be added to 
the database, I can request that they be removed by contacting Chris 
Oliver on  or by post at the 







5. I understand the Professor Chris Oliver holds ultimate responsibility for 
the database. 
 






We will provide you with a signed copy of this consent form should you wish to 
refer to it at later date. A copy will also be held by the Cerebra centre as 

















          
 
 
Consent Form C(a): For individuals over the age of 16 who are not able to 
provide consent. 
 
Understanding Behaviour, Emotion and Movement in Individuals with [insert 
syndrome] 
 
Study Director: Professor Chris Oliver 
 
Before deciding whether to participate, please ensure you read the information on 
acting as a personal consultee in the (attached document/link) for the person you care 
for.   
 
 
SECTION 1: Please read the following statements:     
Please initital each statement or online tick box 
  
1. I (your name) __________________have been consulted about 
(name of participant) _______________’s participation in the 
above research project. I confirm that I have read the information 
sheet dated [insert date] for the above study. I have had the 
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opportunity to ask questions about the study and understand what  
is involved. 
 
2. In my opinion he/she would have no objection to taking part in the above study. 
 
3. I understand that I can request he/she is withdrawn from the study 
at any time without giving any reason and without his/her care or 
legal rights being affected. 
 
4. I understand that relevant sections of his/her GP medical notes or 
records confirming genetic diagnosis and health status may be 
looked at by members of the Cerebra Centre for 
Neurodevelopmental Disorders research team at the University of 
Birmingham, where it is relevant to this research project. I give 
permission for these individuals to have access to these records. 
 
5. I agree to his/her GP being informed of their participation in the 
study, where access to medical records is required. 
 
6. I understand that as part of the above study, audio/video 
recordings of participants may be made and stored for further 
review 
 
7. I understand that the University of Birmingham will hold the 
copyright of any audio/video recordings collected during the 
study but that this does not entitle the University of Birmingham 
to edit, copy or use the videos for teaching purposes without my 









8. I am happy to be contacted in the future by the University of 
Birmingham regarding the use of audio/video recordings for 
teaching purposes. 
 
9. I agree to take part in the above study.  
 
Optional clauses: The statements below are optional. Not consenting to these will 
not impact you and your child/the person you care for’s involvement in this project, 
nor will it affect the level of feedback you will receive:  
            
       YES         NO 
1. I understand that he/she may be asked to provide a saliva 
sample that will be used for analysis of genetic 
information and that the information found will not be 
fed back to me routinely. 
 
2. I agree to the University of Birmingham research team 
sharing his/her research data with any professionals or 



















SECTION 3: This is optional and allows you to provide consent for us to keep 
your personal details on the Regular Participant Database.  See section titled 
‘Regular Participant Database’ in the information sheet.  
           
Please initial each statement or online tick box … 
 
6. I have read and understood the section titled ‘Regular Participant 
Database’ and I would like my and the person I care for’s personal 
details to be added to the database. 
 
7. I understand that my name and contact details will be kept by the 
research team at the University of Birmingham in accordance with 
the provisions of the Data Protection Act 1998 and I will be 
contacted by an approved member of the team with information 
about future research that I and the person I care for may like to 
participate in. 
 
8. I understand that if my details are held on the database it will be 
possible for the research team to trace the results of the 
assessments that I complete in this project back to me and the 
person I care for so that they can look at changes over time if we 






9. I understand that even after I have agreed for my details to be 
added to the database, I can request that they be removed by 
contacting Chris Oliver on or at 
or by post at the School of Psychology, 
University of Birmingham, Edgbaston, B15 2TT. 
 
10. I understand the Professor Chris Oliver holds ultimate 
responsibility for the database. 
 





We will provide you with a signed copy of this consent form should you wish to 
refer to it at later date. A copy will also be held by the Cerebra centre as 





Consent form for parents/carers of participants who under 16 and NOT able to 
consent 





          
  
Consent Form B: For children under the age of 16 who are not able to provide 
consent. 
 
Understanding Behaviour, Emotion and Movement in Individuals with [insert 
syndrome] 
 
Study Director: Professor Chris Oliver 
 
Please complete this section if you are a parent/ guardian of a child (under 16 
years) with [insert syndrome] who is not able to provide consent. 
Please initial each statement or online tick]… 
 
1. I confirm that I have read and understood the information sheet dated 
[insert date] for the above study. I have had the opportunity to consider 
the information, ask questions and have had these answered 
satisfactorily. 
 
2. I understand that my participation and that of my child/person I care for 




any reason, without my or that of my child’s/person I care for’s medical 
care or legal rights being affected. 
 
3. I understand that relevant sections of my child’s/person I care for’s GP 
medical notes or records confirming genetic diagnosis and health status 
may be looked at by members of the Cerebra Centre for 
Neurodevelopmental Disorders research team at the University of 
Birmingham, where it is relevant to this research project. I give 
permission for these individuals to have access to these records. 
 
 
4. I agree to my child’s/person I care for’s GP being informed of my 
participation and that of my child/person I care for’s in the study, where 
access to my child’s/person I care for’s medical records is required. 
 
5. I understand that as part of the above study, audio/video 
recordings of participants may be made and stored for further 
review 
 
6. I understand that the University of Birmingham will hold the 
copyright of any audio/video recordings collected during the 
study but that this does not entitle the University of Birmingham 
to edit, copy or use the videos for teaching purposes without my 
written permission.  
 
7. I am happy to be contacted in the future by the University of 
Birmingham regarding the use of audio/video recordings for 
teaching purposes. 
 








Optional clauses: The statements below are optional. Not consenting to these will 
not impact you and your child/the person you care for’s involvement in this project, 
nor will it affect the level of feedback you will receive:  
 
           
          YES   NO 
1. I understand that my child/person I care for may be asked to 
provide a saliva sample that will be used for analysis of genetic 
information and that the information found will not be fed back 
to me routinely. 
 
2. I agree to the University of Birmingham research team sharing 
my research data with any professionals or clinicians working 











Telephone number: ___________________________ Relationship to participant: 
______________________________  
 





We will provide you with a signed copy of this consent form should you wish to 
refer to it at later date. A copy will also be held by the Cerebra centre as 




Testing for normal distribution and that the assumptions for multiple regression are 
met 
 
Table 2.6 Normality tests using the Shapiro-Wilk statistic for key variables in CdLS 
and FXS 
 Statistic df p 
CdLS 
SRS-2 total score .973 31 .600 
ADAMS-GA .949 31 .148 
ASC-ASD total 
score 
.896 31 .006 
IUS-P total score .947 13 .128 
FXS 
SRS-2 total score .952 30 .195 
ADAMS-GA .968 30 .492 
ASC-ASD total 
score 
.960 30 .307 







Table 2.7 Checking assumptions for linear regression with ASC-ASD as dependent 
variable 
Model Cook’s D Durbin 
Watson 
Tolerance VIF 
1 SRS-2  2.386 1.00 1.00 
2 SRS-2 and 
IUS-P 
 2.386 .797 1.254 
3 SRS-2, IUS-
P and Group 
.213 2.386 .964 1.038 
 
Figre 2.1 Normal P-Plot of residuals with  
ASC-ASD as dependent variable 




















Table 2.8 Checking assumptions for linear regression with ADAMS-GA  as 
dependent variable 
 
Model Cook’s D Durbin 
Watson 
Tolerance VIF 
1 SRS-2  2.124 1.00 1.00 
2 SRS-2 and 
IUS-P 
 2.124 .797 1.254 
3 SRS-2, IUS-
P and Group 




Figre 2.3  Normal P-Plot of residuals with  
ADAMS-GA  as dependent variable 













Baron and Kenny’s (1986) causal steps logic applied to the data presented in chapter 
two.  
Baron and Kenny’s causal steps logic (Barron & Kenny, 1986).   






Figure 2.1,  a causal mediational model of IU mediating anxiety in relations to 
autism symptomatology  
 
This analysis involves four steps: 
Step 1: The C Path 
Does X predicts Y? (simple regression analysis) 
Step 2: The a path  
Does X predict M? (simple regression analysis) 
Step 3 The b path 
Does M predict Y? (simple regression analysis) 
The first three steps demonstrate the existence of zero-order relationships variables. 
If one or more of these relationships are not significant, mediation is usually 
considered unlikely (Barron & Kenny, 1986).  
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Step 4- The extent of mediation (multiple regression analysis) 
If X is no longer significant when M is controlled, the finding supports full 
mediation. If X and M both significantly predict Y, the findings support a partial 
mediation.  
 
Mediation analysis was conducted in both CdLS and FXS groups, with both ASC-
ASD total score and ADAMS-GA subscale score as the dependent variable. Table 
2.5 outlines the results for each step.  
In the CdLS group, significant relationships were found for steps 1, 2 and 3  (see 
Table 2.5) for both ASCASD and ADAMS-GA scores as the dependent variable. In 
step 4, the relationship between autism symptomatology (SRS scores) and anxiety 
(ASC-ASD or ADAMS-GA) scores was no longer significant at the <.05 level, 
while the relationship between IU (IUS-P) and anxiety was significant (see table 
2.5). The results from this causal steps approach are therefore consistent with a 
causal mediational model in which the relationship between ASD symptomatology 
and anxiety is almost entirely mediated by IU in CdLS.   
 
In the FXS group, analysis followed the same process as outlined for the CdLS 
group (see Table 2.5). Step 2 of the causal steps model revealed no significant 
relationship between X (SRS) and M (IU). This meant that it was unlikely a 
mediational relationship existed between IU and anxiety and therefore, the final 
steps of the analysis were not undertaken. The results were not consistent with a 
mediating role of IU between autism symptomatology and anxiety.  
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Table 2.5 : A summary of statistical analyses and significant regressions for each 
step of the causal steps model in CdLS and FXS groups 
 













1,32 .146 .382 .028 
Step 2 13.
41 
1,32 .316 .562 .001 
Step 3 62.
38 




















1,32 .267 .517 .002 
Step 2 13.
41 
1,32 .316 .562 .001 
Step 3 40.
81 













             







1,32 .183 .427 .016 
Step 2 1.4
8 







1,32 .162 .403 .022 
Step 2 1.4
8 




Spearman’s rho correlations between autism symptomatology, anxiety and IU in 15 
females with CdLS 
 
Table 2.6 






IUS-P total score 









total score  
 





   .841** 
IUS-P total 
score 
    
*indicates p<.05 
**indicates p<.01 
 
 
 
 
